Home work?
Keep your critical coding and billing tools with you no matter where you work.
Create your Find-A-Code account today!
subscribe
8E4A Paraneoplastic or autoimmune disorders of the nervous system International Classification of Diseases for Mortality and Morbidity Statistics, 11th Revision, v2024-01 Paraneoplastic and autoimmune disorders of the nervous system result from a targeted immune attack on neurons or glial cells in the central (e.g. encephalopathy, ataxia, myelitis) or peripheral nervous systems (peripheral or autonomic neuropathies, neuromuscular junction disorders or myopathy). In the paraneoplastic context, this attack is a consequence of a potentially effective tumour immune response initiated by onco-neural antigens derived from a systemic cancer. In the non-paraneoplastic context termed autoimmune the etiology remains elusive though increasing evidence indicates a preceding infectious trigger in at least some cases. These disorders are commonly multifocal causing injury and symptoms arising from involvement at many levels of the nervous system. A personal or family history of autoimmunity is often found. Accompanying neural and non-organ specific (thyroid peroxidase [TPO] antibodies) autoantibodies may be found. The neural autoantibody profile may be predictive of a specific cancer type and may be associated with a particular neurological phenotype. Exclusion of alternative etiologies (e.g. infections) is important. Response to immunotherapy may support the diagnosis.
sections/codes in this section (8E4A-8E4A) postcoordination Add Stem and/or Extension codes to form a cluster code which adds detail to the condition.
Has causing condition - a selection is required - multiple selections are allowed [select] 1D00 Infectious encephalitis, not elsewhere classified – 1D00.0 Bacterial encephalitis – 1D00.1 Fungal encephalitis – 1D00.2 Parasitic or protozoal encephalitis – 1D00.Y Other specified infectious encephalitis, not elsewhere classified – 1D00.Z Infectious encephalitis, unspecified 1D01 Infectious meningitis, not elsewhere classified – 1D01.0 Bacterial meningitis – 1D01.1 Fungal meningitis – 1D01.2 Parasitic or protozoal meningitis – 1D01.3 Benign recurrent meningitis – 1D01.Y Other specified infectious meningitis, not elsewhere classified – 1D01.Z Infectious meningitis, unspecified –– 1D01.00 Meningitis due to Haemophilus influenzae –– 1D01.0Y Other specified bacterial meningitis –– 1D01.0Z Bacterial meningitis, unspecified 1D02 Infectious myelitis, not elsewhere classified – 1D02.0 Bacterial myelitis – 1D02.1 Viral myelitis – 1D02.2 Fungal myelitis – 1D02.3 Parasitic myelitis – 1D02.Y Other specified infectious myelitis, not elsewhere classified – 1D02.Z Infectious myelitis, unspecified 1D03 Infectious abscess of the central nervous system – 1D03.0 Intraspinal intramedullary abscess – 1D03.1 Intraspinal subdural abscess – 1D03.2 Intraspinal extradural abscess – 1D03.3 Intracranial abscess – 1D03.4 Intraspinal epidural abscess – 1D03.5 Spinal cord abscess – 1D03.Y Other specified site of infectious abscess of the central nervous system – 1D03.Z Infectious abscess of the central nervous system, site unspecified –– 1D03.30 Deep cerebral hemispheric abscess –– 1D03.31 Abscess of the corpus callosum –– 1D03.32 Pituitary abscess –– 1D03.33 Multiple or widespread intracranial abscess –– 1D03.3Y Other specified intracranial abscess –– 1D03.3Z Intracranial abscess, unspecified 1D04 Infectious granulomas of the central nervous system – 1D04.0 Parasitic intracerebral granuloma – 1D04.1 Intracranial granuloma – 1D04.2 Intraspinal intramedullary granuloma – 1D04.3 Intraspinal subdural granuloma – 1D04.4 Intraspinal extradural granuloma – 1D04.5 Intraspinal epidural granuloma – 1D04.Y Other specified site of infectious granulomas of the central nervous system – 1D04.Z Infectious granulomas of the central nervous system, site unspecified –– 1D04.10 Fungal intracranial granuloma –– 1D04.1Y Other specified intracranial granuloma –– 1D04.1Z Intracranial granuloma, unspecified 1D05 Infectious cysts of the central nervous system – 1D05.0 Epidural infectious cyst – 1D05.1 Subdural infectious cyst – 1D05.Y Other specified infectious cysts of the central nervous system – 1D05.Z Infectious cysts of the central nervous system, unspecified 1D0Y Other specified non-viral and unspecified infections of the central nervous system 1D0Z Non-viral and unspecified infections of the central nervous system, unspecified 2A00 Primary neoplasms of brain – 2A00.0 Gliomas of brain – 2A00.1 Embryonal tumours of brain – 2A00.2 Tumours of neuroepithelial tissue of brain – 2A00.3 Central neurocytoma of brain – 2A00.4 Astroblastoma of the brain – 2A00.5 Primary neoplasm of brain of unknown or unspecified type –– 2A00.00 Glioblastoma of brain –– 2A00.0Y Other specified gliomas of brain –– 2A00.0Z Gliomas of brain, unspecified –– 2A00.10 Medulloblastoma of brain –– 2A00.11 Central primitive neuroectodermal tumour –– 2A00.1Y Other specified embryonal tumours of brain –– 2A00.1Z Embryonal tumours of brain, unspecified –– 2A00.20 Tumours of the pineal gland or pineal region –– 2A00.21 Mixed neuronal-glial tumours –– 2A00.22 Choroid plexus tumours –– 2A00.2Y Other specified tumours of neuroepithelial tissue of brain –– 2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified 2A01 Primary neoplasms of meninges – 2A01.0 Meningiomas – 2A01.1 Mesenchymal tumours of meninges – 2A01.2 Primary neoplasm of meninges of unknown or unspecified type –– 2A01.00 Primary malignant meningioma –– 2A01.0Y Other specified meningiomas –– 2A01.0Z Meningiomas, unspecified 2A02 Primary neoplasm of spinal cord, cranial nerves or remaining parts of central nervous system – 2A02.0 Gliomas of spinal cord, cranial nerves or other parts of the central nervous system – 2A02.1 Tumours of cranial or paraspinal nerves – 2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type – 2A02.3 Benign neoplasm of cranial nerves – 2A02.4 Benign neoplasm of spinal cord –– 2A02.00 Glioblastoma of spinal cord, cranial nerves or other parts of central nervous system –– 2A02.0Y Other specified gliomas of spinal cord, cranial nerves or other parts of the central nervous system –– 2A02.0Z Gliomas of spinal cord, cranial nerves or other parts of the central nervous system, unspecified –– 2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves –– 2A02.11 Paraspinal neuroblastoma –– 2A02.12 Malignant neoplasm of the optic nerve –– 2A02.1Y Other specified tumours of cranial or paraspinal nerves –– 2A02.1Z Tumours of cranial or paraspinal nerves, unspecified 2A0Z Other and unspecified neoplasms of brain or central nervous system – 2A20 Non mast cell myeloproliferative neoplasms –– 2A20.0 Chronic myelogenous leukaemia, BCR-ABL1-positive –– 2A20.1 Chronic neutrophilic leukaemia –– 2A20.2 Primary myelofibrosis –– 2A20.3 Chronic eosinophilic leukaemia, not elsewhere classified –– 2A20.4 Polycythaemia vera –– 2A20.5 Non mast cell myeloproliferative neoplasm, unclassifiable –– 2A20.Y Other specified non mast cell myeloproliferative neoplasms –– 2A20.Z Non mast cell myeloproliferative neoplasms, unspecified ––– 2A20.00 Chronic myelogenous leukaemia with blast crisis ––– 2A20.01 Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive ––– 2A20.02 Chronic myelogenous leukaemia, t(9:22)(q34; q11) ––– 2A20.03 Naegeli-type monocytic leukaemia ––– 2A20.0Y Other specified chronic myelogenous leukaemia, BCR-ABL1-positive ––– 2A20.0Z Chronic myelogenous leukaemia, BCR-ABL1-positive, unspecified – 2A21 Mastocytosis –– 2A21.0 Systemic mastocytosis –– 2A21.1 Cutaneous mastocytosis –– 2A21.2 Mast cell sarcoma –– 2A21.3 Extracutaneous mastocytoma –– 2A21.Y Other specified mastocytosis –– 2A21.Z Mastocytosis, unspecified ––– 2A21.00 Mast cell leukaemia ––– 2A21.0Y Other specified systemic mastocytosis ––– 2A21.0Z Systemic mastocytosis, unspecified ––– 2A21.10 Urticaria pigmentosa ––– 2A21.1Y Other specified cutaneous mastocytosis ––– 2A21.1Z Cutaneous mastocytosis, unspecified – 2A22 Other and unspecified myeloproliferative neoplasms – 2A30 Refractory anaemia – 2A31 Refractory neutropaenia – 2A32 Refractory thrombocytopenia – 2A33 Refractory anaemia with ring sideroblasts – 2A34 Refractory cytopenia with multi-lineage dysplasia – 2A35 Refractory anaemia with excess of blasts – 2A36 Myelodysplastic syndrome with isolated del(5q) – 2A37 Myelodysplastic syndrome, unclassifiable – 2A38 Refractory cytopenia of childhood – 2A3Y Other specified myelodysplastic syndromes – 2A3Z Myelodysplastic syndromes, unspecified – 2A40 Chronic myelomonocytic leukaemia – 2A41 Atypical chronic myeloid leukaemia, BCR-ABL1-negative – 2A42 Juvenile myelomonocytic leukaemia –– 2A42.0 Juvenile myelomonocytic leukaemia in complete remission –– 2A42.Y Other specified juvenile myelomonocytic leukaemia –– 2A42.Z Juvenile myelomonocytic leukaemia, unspecified – 2A43 Refractory anaemia with ring sideroblasts associated with marked thrombocytosis – 2A44 Myeloproliferative and myelodysplastic disease, unclassifiable – 2A4Y Other specified myelodysplastic and myeloproliferative neoplasms – 2A4Z Myelodysplastic and myeloproliferative neoplasms, unspecified – 2A50 Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement – 2A51 Myeloid neoplasm associated with PDGFRB rearrangement – 2A52 Myeloid or lymphoid neoplasms with FGFR1 abnormalities – 2A5Z Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified 2A60 Acute myeloid leukaemias and related precursor neoplasms – 2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities – 2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes – 2A60.2 Therapy-related myeloid neoplasms – 2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types – 2A60.4 Myeloid proliferation associated with Down syndrome – 2A60.5 Blastic plasmacytoid dendritic cell neoplasm – 2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms – 2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified –– 2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome –– 2A60.2Y Other specified therapy-related myeloid neoplasms –– 2A60.2Z Therapy-related myeloid neoplasms, unspecified –– 2A60.30 Acute myeloid leukaemia with minimal differentiation –– 2A60.31 Acute myeloid leukaemia without maturation –– 2A60.32 Acute myeloid leukaemia with maturation –– 2A60.33 Acute myelomonocytic leukaemia –– 2A60.34 Acute monoblastic or monocytic leukaemia –– 2A60.35 Acute erythroid leukaemia –– 2A60.36 Acute megakaryoblastic leukaemia –– 2A60.37 Acute basophilic leukaemia –– 2A60.38 Acute panmyelosis with myelofibrosis –– 2A60.39 Myeloid sarcoma –– 2A60.3Y Other specified acute myeloid leukaemia, not elsewhere classified by criteria of other types –– 2A60.3Z Acute myeloid leukaemia, unspecified –– 2A60.40 Transient abnormal myelopoiesis –– 2A60.41 Myeloid leukaemia associated with Down syndrome –– 2A60.4Y Other specified myeloid proliferation associated with Down syndrome –– 2A60.4Z Myeloid proliferation associated with Down syndrome, unspecified 2A61 Acute leukaemias of ambiguous lineage – 2A70 Precursor B-lymphoblastic neoplasms –– 2A70.0 B lymphoblastic leukaemia or lymphoma, not elsewhere classified –– 2A70.1 B lymphoblastic leukaemia or lymphoma with t(9:22) (q34;q11.2); BCR-ABL1 –– 2A70.Y Other B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities – 2A71 Precursor T-lymphoblastic neoplasms – 2A7Z Precursor lymphoid neoplasms, unspecified – 2A80 Follicular lymphoma –– 2A80.0 Follicular lymphoma grade 1 –– 2A80.1 Follicular lymphoma grade 2 –– 2A80.2 Follicular lymphoma grade 3 –– 2A80.3 Primary cutaneous follicle centre lymphoma –– 2A80.4 Paediatric type follicular lymphoma –– 2A80.5 Follicular lymphoma in situ –– 2A80.6 Follicular lymphoma of small intestine –– 2A80.Y Other specified follicular lymphoma –– 2A80.Z Follicular lymphoma, unspecified – 2A81 Diffuse large B-cell lymphomas –– 2A81.0 Primary mediastinal large B-cell lymphoma –– 2A81.1 Intravascular large B-cell lymphoma –– 2A81.2 Plasmablastic lymphoma –– 2A81.3 Lymphomatoid granulomatosis –– 2A81.4 T-cell/histiocyte rich large B-cell lymphoma –– 2A81.5 Primary diffuse large B-cell lymphoma of central nervous system –– 2A81.6 Epstein-Barr Virus-positive diffuse large B-cell lymphoma of the elderly –– 2A81.7 Diffuse large B-cell lymphoma associated with chronic inflammation –– 2A81.8 ALK-positive large B-cell lymphoma –– 2A81.9 Primary effusion lymphoma –– 2A81.A Primary cutaneous diffuse large B-cell lymphoma, leg type –– 2A81.Y Other specified diffuse large B-cell lymphomas –– 2A81.Z Diffuse large B-cell lymphoma, not otherwise specified – 2A82 Mature B-cell neoplasm with leukaemic behaviour –– 2A82.0 Chronic lymphocytic leukaemia or small lymphocytic lymphoma –– 2A82.1 B-cell prolymphocytic leukaemia –– 2A82.2 Hairy-cell leukaemia –– 2A82.3 Splenic B-cell lymphoma or leukaemia, unclassifiable –– 2A82.Y Other specified mature B-cell neoplasm with leukaemic behaviour –– 2A82.Z Mature B-cell neoplasm with leukaemic behaviour, unspecified ––– 2A82.00 Chronic lymphocytic leukaemia of B-cell type ––– 2A82.0Y Other specified chronic lymphocytic leukaemia or small lymphocytic lymphoma ––– 2A82.0Z Chronic lymphocytic leukaemia or small lymphocytic lymphoma, unspecified ––– 2A82.10 B-cell prolymphocytic leukaemia in complete remission ––– 2A82.1Y Other specified b-cell prolymphocytic leukaemia ––– 2A82.1Z B-cell prolymphocytic leukaemia, unspecified – 2A83 Plasma cell neoplasms –– 2A83.0 Monoclonal gammopathy of undetermined significance –– 2A83.1 Plasma cell myeloma –– 2A83.2 Solitary plasmacytoma –– 2A83.3 Extraosseous plasmacytoma –– 2A83.4 Plasma cell leukaemia –– 2A83.5 Monoclonal immunoglobulin deposition disease –– 2A83.Y Other specified multiple myeloma and plasma cell neoplasms –– 2A83.Z Plasma cell neoplasm, unspecified ––– 2A83.50 Heavy chain deposition disease ––– 2A83.51 Light and heavy chain deposition disease ––– 2A83.52 Light chain deposition disease – 2A84 Heavy chain diseases or malignant immunoproliferative diseases –– 2A84.0 Alpha heavy chain disease –– 2A84.1 Gamma heavy chain disease –– 2A84.2 Mu heavy chain disease –– 2A84.Y Other specified malignant immunoproliferative diseases –– 2A84.Z Heavy chain diseases, unspecified – 2A85 Other specified mature B-cell neoplasms or lymphoma –– 2A85.0 Nodal marginal zone lymphoma –– 2A85.1 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach –– 2A85.2 Extranodal marginal zone B-cell lymphoma, primary site skin –– 2A85.3 Extranodal marginal zone B-cell lymphoma, primary site excluding stomach or skin –– 2A85.4 Lymphoplasmacytic lymphoma –– 2A85.5 Mantle cell lymphoma –– 2A85.6 Burkitt lymphoma including Burkitt leukaemia –– 2A85.Y Further specified mature B-cell neoplasms or lymphoma – 2A86 B-cell lymphoma, mixed features –– 2A86.0 Malignant lymphoma of B cell type, not elsewhere classified –– 2A86.1 B-cell lymphoma unclassifiable with features intermediate between Burkitt lymphoma and diffuse large B-cell lymphoma –– 2A86.2 B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma –– 2A86.Y Other specified B-cell lymphoma, mixed features –– 2A86.Z B-cell lymphoma, mixed features, unspecified – 2A8Z Mature B-cell neoplasms, unspecified – 2A90 Mature T-cell lymphoma, specified types, nodal or systemic –– 2A90.0 T-cell prolymphocytic leukaemia –– 2A90.1 T-cell large granular lymphocytic leukaemia –– 2A90.2 Chronic lymphoproliferative disorders of NK-cells –– 2A90.3 Aggressive NK cell leukaemia –– 2A90.4 Systemic Epstein-Barr Virus-positive T-cell lymphoma of childhood –– 2A90.5 Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated –– 2A90.6 Extranodal NK/T-cell lymphoma, nasal type –– 2A90.7 Enteropathy associated T-cell lymphoma –– 2A90.8 Hepatosplenic T-cell lymphoma –– 2A90.9 Angioimmunoblastic T-cell lymphoma –– 2A90.A Anaplastic large cell lymphoma, ALK-positive –– 2A90.B Anaplastic large cell lymphoma, ALK-negative –– 2A90.C Peripheral T-cell lymphoma, not otherwise specified –– 2B00 Subcutaneous panniculitis-like T-cell lymphoma –– 2B01 Mycosis fungoides –– 2B02 Sézary syndrome –– 2B03 Primary cutaneous CD30-positive T-cell lymphoproliferative disorders ––– 2B03.0 Primary cutaneous CD30-positive anaplastic large cell lymphoma ––– 2B03.1 Lymphomatoid papulosis –– 2B0Y Other specified primary cutaneous mature T-cell or NK-cell lymphomas and lymphoproliferative disorders –– 2B0Z Primary cutaneous T-cell lymphoma of undetermined or unspecified type – 2B2Y Other specified mature T-cell or NK-cell neoplasms – 2B2Z Mature T-cell or NK-cell neoplasms, unspecified 2B30 Hodgkin lymphoma – 2B30.0 Nodular lymphocyte predominant Hodgkin lymphoma – 2B30.1 Classical Hodgkin lymphoma – 2B30.Z Hodgkin lymphoma, unspecified –– 2B30.10 Nodular sclerosis classical Hodgkin lymphoma –– 2B30.11 Lymphocyte-rich classical Hodgkin lymphoma –– 2B30.12 Mixed cellularity classical Hodgkin lymphoma –– 2B30.13 Lymphocyte depleted classical Hodgkin lymphoma –– 2B30.1Z Classical Hodgkin lymphoma, unspecified 2B31 Histiocytic or dendritic cell neoplasms – 2B31.0 Juvenile xanthogranuloma – 2B31.1 Histiocytic sarcoma – 2B31.2 Langerhans cell histiocytosis – 2B31.3 Langerhans cell sarcoma – 2B31.4 Interdigitating dendritic cell sarcoma – 2B31.5 Follicular dendritic cell sarcoma – 2B31.6 Indeterminate cell histiocytosis – 2B31.7 Fibroblastic reticular cell tumour – 2B31.Y Other specified histiocytic or dendritic cell neoplasms – 2B31.Z Histiocytic or dendritic cell neoplasms, unspecified –– 2B31.20 Langerhans cell histiocytosis involving the skin –– 2B31.2Y Other specified Langerhans cell histiocytosis –– 2B31.2Z Langerhans cell histiocytosis, unspecified 2B32 Immunodeficiency-associated lymphoproliferative disorders – 2B32.0 Post-transplant lymphoproliferative disorder, early lesion – 2B32.1 Reactive plasmacytic hyperplasia – 2B32.2 Post-transplant lymphoproliferative disorder, Infectious mononucleosis-like – 2B32.3 Polymorphic post-transplant lymphoproliferative disorder – 2B32.Y Other specified immunodeficiency-associated lymphoproliferative disorders – 2B32.Z Immunodeficiency-associated lymphoproliferative disorders, unspecified 2B33 Malignant haematopoietic neoplasms without further specification – 2B33.0 Acute leukaemia, not elsewhere classified – 2B33.1 Myeloid leukaemia – 2B33.2 Chronic myeloid leukaemia, not elsewhere classified – 2B33.3 Lymphoid leukaemia, not elsewhere classified – 2B33.4 Leukaemia, unspecified – 2B33.5 Malignant lymphoma, not elsewhere classified – 2B33.Y Other malignant haematopoietic neoplasms without further specification 2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified –– 2B50 Chondrosarcoma, primary site ––– 2B50.0 Chondrosarcoma of bone or articular cartilage of limbs ––– 2B50.1 Chondrosarcoma of bone or articular cartilage of pelvis ––– 2B50.2 Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle ––– 2B50.Y Chondrosarcoma of bone or articular cartilage of other specified sites ––– 2B50.Z Chondrosarcoma of bone or articular cartilage of unspecified sites –– 2B51 Osteosarcoma, primary site ––– 2B51.0 Osteosarcoma of bone or articular cartilage of jaw ––– 2B51.1 Osteosarcoma of bone or articular cartilage of limbs ––– 2B51.2 Osteosarcoma of bone or articular cartilage of pelvis ––– 2B51.Y Osteosarcoma of bone and articular cartilage of other specified sites ––– 2B51.Z Osteosarcoma of bone and articular cartilage of unspecified sites –– 2B52 Ewing sarcoma, primary site ––– 2B52.0 Ewing sarcoma of bone or articular cartilage of limbs ––– 2B52.1 Ewing sarcoma of bone or articular cartilage of pelvis ––– 2B52.2 Ewing sarcoma of bone or articular cartilage of ribs ––– 2B52.3 Ewing sarcoma of soft tissue ––– 2B52.Y Ewing sarcoma of bone and articular cartilage of other specified sites ––– 2B52.Z Ewing sarcoma of bone and articular cartilage of unspecified sites –– 2B53 Fibroblastic or myofibroblastic tumour, primary site ––– 2B53.0 Myxofibrosarcoma, primary site ––– 2B53.1 Fibroblastic or myofibroblastic tumour of skin ––– 2B53.Y Other specified fibroblastic or myofibroblastic tumour, primary site ––– 2B53.Z Fibroblastic or myofibroblastic tumour, primary site, unspecified –– 2B54 Unclassified pleomorphic sarcoma, primary site ––– 2B54.0 Unclassified pleomorphic sarcoma of skin ––– 2B54.1 Unclassified pleomorphic sarcoma of retroperitoneum or peritoneum ––– 2B54.Y Unclassified pleomorphic sarcoma, primary site, other specified site ––– 2B54.Z Unclassified pleomorphic sarcoma, primary site, unspecified site –– 2B55 Rhabdomyosarcoma, primary site ––– 2B55.0 Rhabdomyosarcoma of the oral cavity or pharynx ––– 2B55.1 Rhabdomyosarcoma of respiratory or intrathoracic organs ––– 2B55.2 Rhabdomyosarcoma of male genital organs ––– 2B55.Y Rhabdomyosarcoma, other specified primary site ––– 2B55.Z Rhabdomyosarcoma, unspecified primary site –– 2B56 Angiosarcoma, primary site ––– 2B56.0 Angiosarcoma of heart ––– 2B56.1 Angiosarcoma of skin ––– 2B56.2 Angiosarcoma of breast ––– 2B56.3 Angiosarcoma of liver ––– 2B56.Y Angiosarcoma, other specified primary site ––– 2B56.Z Angiosarcoma, unspecified primary site –– 2B57 Kaposi sarcoma, primary site ––– 2B57.0 Kaposi sarcoma of lung ––– 2B57.1 Kaposi sarcoma of skin ––– 2B57.2 Kaposi sarcoma of gastrointestinal sites ––– 2B57.Y Kaposi sarcoma of other specified primary sites ––– 2B57.Z Kaposi sarcoma of unspecified primary site –– 2B58 Leiomyosarcoma, primary site ––– 2B58.0 Leiomyosarcoma of retroperitoneum or peritoneum ––– 2B58.1 Leiomyosarcoma of uterus ––– 2B58.2 Leiomyosarcoma of stomach ––– 2B58.Y Leiomyosarcoma, other specified primary site ––– 2B58.Z Leiomyosarcoma, unspecified primary site –– 2B59 Liposarcoma, primary site ––– 2B59.0 Liposarcoma of soft tissue of limb ––– 2B59.1 Liposarcoma of retroperitoneum or peritoneum ––– 2B59.2 Liposarcoma of male genital organs ––– 2B59.Y Liposarcoma, other specified primary site ––– 2B59.Z Liposarcoma, unspecified primary site –– 2B5A Synovial sarcoma, primary site ––– 2B5A.0 Synovial sarcoma of soft tissues of limb ––– 2B5A.1 Synovial sarcoma of respiratory or intra-thoracic organs ––– 2B5A.Y Synovial sarcoma, other specified primary site ––– 2B5A.Z Synovial sarcoma, unspecified primary site –– 2B5B Gastrointestinal stromal tumour, primary site ––– 2B5B.0 Gastrointestinal stromal tumour of stomach ––– 2B5B.1 Gastrointestinal stromal tumour of small intestine ––– 2B5B.Y Gastrointestinal stromal tumour of other gastrointestinal sites ––– 2B5B.Z Gastrointestinal stromal tumour of unspecified gastrointestinal sites –– 2B5C Endometrial stromal sarcoma, primary site –– 2B5D Malignant mixed epithelial mesenchymal tumour, primary site ––– 2B5D.0 Malignant mixed epithelial mesenchymal tumour of ovary ––– 2B5D.1 Malignant mixed epithelial and mesenchymal tumour of corpus uteri ––– 2B5D.Y Malignant mixed epithelial mesenchymal tumour, other specified primary site ––– 2B5D.Z Malignant mixed epithelial mesenchymal tumour, unspecified primary site –– 2B5E Malignant nerve sheath tumour of peripheral nerves or autonomic nervous system, primary site –– 2B5F Sarcoma, not elsewhere classified, primary site ––– 2B5F.0 Sarcoma, not elsewhere classified of uterus ––– 2B5F.1 Sarcoma, not elsewhere classified of retroperitoneum or peritoneum ––– 2B5F.2 Sarcoma, not elsewhere classified of other specified sites ––– 2B5F.3 Sarcoma, not elsewhere classified, primary site unknown –––– 2B5F.10 Myosarcomas of omentum –––– 2B5F.1Y Other specified sarcoma, not elsewhere classified of retroperitoneum or peritoneum –––– 2B5F.1Z Sarcoma, not elsewhere classified of retroperitoneum or peritoneum, unspecified –– 2B5G Myosarcoma of uterus, part not specified –– 2B5H Well differentiated lipomatous tumour, primary site –– 2B5J Malignant miscellaneous tumours of bone or articular cartilage of other or unspecified sites –– 2B5K Unspecified malignant soft tissue tumours or sarcomas of bone or articular cartilage of other or unspecified sites –– 2B5Y Other specified malignant mesenchymal neoplasms –– 2B5Z Malignant mesenchymal neoplasm of unspecified type –– 2B60 Malignant neoplasms of lip ––– 2B60.0 Basal cell carcinoma of lip ––– 2B60.1 Squamous cell carcinoma of lip ––– 2B60.Y Other specified malignant neoplasms of lip ––– 2B60.Z Malignant neoplasms of lip, unspecified –– 2B61 Malignant neoplasms of base of tongue ––– 2B61.0 Squamous cell carcinoma of the base of the tongue ––– 2B61.Y Other specified malignant neoplasms of base of tongue ––– 2B61.Z Malignant neoplasms of base of tongue, unspecified –– 2B62 Malignant neoplasms of other or unspecified parts of tongue ––– 2B62.0 Squamous cell carcinoma of other or unspecified parts of tongue ––– 2B62.1 Malignant neoplasms of lingual tonsil ––– 2B62.Y Other specified malignant neoplasms of other and unspecified parts of tongue ––– 2B62.Z Malignant neoplasms of other or unspecified parts of tongue, unspecified –––– 2B62.10 Squamous cell carcinoma of lingual tonsil –––– 2B62.1Z Malignant neoplasms of lingual tonsil, unspecified –– 2B63 Malignant neoplasms of gum ––– 2B63.0 Squamous cell carcinoma of gum ––– 2B63.Y Other specified malignant neoplasm of gum ––– 2B63.Z Malignant neoplasms of gum, unspecified –– 2B64 Malignant neoplasms of floor of mouth ––– 2B64.0 Squamous cell carcinoma of floor of mouth ––– 2B64.Y Other specified malignant neoplasm of floor of mouth ––– 2B64.Z Malignant neoplasms of floor of mouth, unspecified –– 2B65 Malignant neoplasms of palate ––– 2B65.0 Adenocarcinoma of palate ––– 2B65.1 Squamous cell carcinoma of palate ––– 2B65.Y Other specified malignant neoplasm of palate ––– 2B65.Z Malignant neoplasms of palate, unspecified –– 2B66 Malignant neoplasms of other or unspecified parts of mouth ––– 2B66.0 Squamous cell carcinoma of other or unspecified parts of mouth ––– 2B66.Y Other specified malignant neoplasms of other and unspecified parts of mouth ––– 2B66.Z Malignant neoplasms of other or unspecified parts of mouth, unspecified –– 2B67 Malignant neoplasms of parotid gland ––– 2B67.0 Adenocarcinoma of parotid gland ––– 2B67.1 Squamous cell carcinoma of parotid gland ––– 2B67.Y Other specified malignant neoplasms of parotid gland ––– 2B67.Z Malignant neoplasms of parotid gland, unspecified –– 2B68 Malignant neoplasms of submandibular or sublingual glands ––– 2B68.0 Adenocarcinoma of submandibular or sublingual glands ––– 2B68.1 Squamous cell carcinoma of submandibular or sublingual glands ––– 2B68.2 Other specified malignant neoplasms of submandibular or sublingual glands ––– 2B68.Z Malignant neoplasms of submandibular or sublingual glands, unspecified –– 2B69 Malignant neoplasms of tonsil ––– 2B69.0 Squamous cell carcinoma of tonsil ––– 2B69.1 Other specified malignant neoplasms of tonsil ––– 2B69.Z Malignant neoplasms of tonsil, unspecified –– 2B6A Malignant neoplasms of oropharynx ––– 2B6A.0 Squamous cell carcinoma of oropharynx ––– 2B6A.Y Other specified malignant neoplasms of oropharynx ––– 2B6A.Z Malignant neoplasms of oropharynx, unspecified –– 2B6B Malignant neoplasms of nasopharynx ––– 2B6B.0 Squamous cell carcinoma of nasopharynx ––– 2B6B.1 Malignant epithelial neoplasms of nasopharynx, unspecified type ––– 2B6B.2 Malignant neoplasms of pharyngeal tonsil ––– 2B6B.Y Other specified malignant neoplasms of nasopharynx ––– 2B6B.Z Malignant neoplasms of nasopharynx, unspecified –––– 2B6B.20 Squamous cell carcinoma of pharyngeal tonsil –––– 2B6B.21 Other or unspecified malignant epithelial neoplasm of pharyngeal tonsil –––– 2B6B.2Y Other specified malignant neoplasms of pharyngeal tonsil –––– 2B6B.2Z Malignant neoplasm of pharyngeal tonsil without mention of type –– 2B6C Malignant neoplasms of piriform sinus ––– 2B6C.0 Squamous cell carcinoma of piriform sinus ––– 2B6C.Y Other specified malignant neoplasms of piriform sinus ––– 2B6C.Z Malignant neoplasms of piriform sinus, unspecified –– 2B6D Malignant neoplasms of hypopharynx ––– 2B6D.0 Squamous cell carcinoma of hypopharynx and variants ––– 2B6D.Y Other specified malignant neoplasms of hypopharynx ––– 2B6D.Z Malignant neoplasms of hypopharynx, unspecified –– 2B6E Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.0 Squamous cell carcinoma of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Y Other specified malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx ––– 2B6E.Z Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx, unspecified –– 2B6Y Other specified malignant neoplasms of lip, oral cavity or pharynx –– 2B70 Malignant neoplasms of oesophagus ––– 2B70.0 Adenocarcinoma of oesophagus ––– 2B70.1 Squamous cell carcinoma of oesophagus ––– 2B70.Y Other specified malignant neoplasms of oesophagus ––– 2B70.Z Malignant neoplasms of oesophagus, unspecified –––– 2B70.00 Barrett adenocarcinoma –––– 2B70.0Y Other specified adenocarcinoma of oesophagus –––– 2B70.0Z Adenocarcinoma of oesophagus, unspecified –– 2B71 Malignant neoplasms of oesophagogastric junction ––– 2B71.0 Adenocarcinoma of oesophagogastric junction ––– 2B71.Y Other specified malignant neoplasm of oesophagogastric junction ––– 2B71.Z Malignant neoplasms of oesophagogastric junction, unspecified –– 2B72 Malignant neoplasms of stomach ––– 2B72.0 Adenocarcinoma of stomach ––– 2B72.1 Malignant neuroendocrine neoplasm of stomach ––– 2B72.Y Other specified malignant neoplasms of stomach ––– 2B72.Z Malignant neoplasms of stomach, unspecified ––– 2B80 Malignant neoplasms of small intestine –––– 2B80.0 Malignant neoplasms of duodenum –––– 2B80.1 Malignant neoplasms of jejunum or ileum –––– 2B80.2 Malignant neoplasms of small intestine, site unspecified –––– 2B80.Y Other specified malignant neoplasms of small intestine –––– 2B80.Z Malignant neoplasms of small intestine, unspecified ––––– 2B80.00 Adenocarcinoma of duodenum ––––– 2B80.01 Neuroendocrine neoplasm of duodenum ––––– 2B80.0Y Other specified malignant neoplasms of the duodenum ––––– 2B80.0Z Malignant neoplasms of duodenum, unspecified ––––– 2B80.10 Adenocarcinoma of jejunum or ileum ––––– 2B80.11 Neuroendocrine neoplasms of jejunum or ileum ––––– 2B80.1Y Other specified malignant neoplasms of jejunum or ileum ––––– 2B80.1Z Malignant neoplasms of jejunum or ileum, unspecified ––––– 2B80.20 Adenocarcinoma of small intestine, site unspecified ––––– 2B80.21 Neuroendocrine neoplasms of small intestine, site unspecified ––––– 2B80.2Y Other specified malignant neoplasms of small intestine, site unspecified ––– 2B81 Malignant neoplasms of appendix –––– 2B81.0 Adenocarcinoma of appendix –––– 2B81.2 Neuroendocrine neoplasms of appendix –––– 2B81.Y Other specified malignant neoplasms of appendix –––– 2B81.Z Malignant neoplasms of appendix, unspecified ––––– 2B81.00 Mucinous adenocarcinoma of appendix –––– 2B90 Malignant neoplasms of colon ––––– 2B90.0 Malignant neoplasm of ascending colon and right flexure of colon ––––– 2B90.1 Malignant neoplasm of descending colon and splenic flexure of colon ––––– 2B90.2 Malignant neoplasm of transverse colon ––––– 2B90.3 Malignant neoplasm of sigmoid colon ––––– 2B90.Y Other specified malignant neoplasms of colon ––––– 2B90.Z Malignant neoplasms of colon, unspecified –––––– 2B90.00 Adenocarcinoma of ascending colon or right flexure of colon –––––– 2B90.0Y Other specified malignant neoplasm of ascending colon and right flexure of colon –––––– 2B90.0Z Malignant neoplasm of ascending colon and right flexure of colon, unspecified –––––– 2B90.10 Adenocarcinoma of descending colon or splenic flexure of colon –––––– 2B90.1Y Other specified malignant neoplasm of descending colon and splenic flexure of colon –––––– 2B90.1Z Malignant neoplasm of descending colon and splenic flexure of colon, unspecified –––––– 2B90.20 Adenocarcinoma of transverse colon –––––– 2B90.2Y Other specified malignant neoplasm of transverse colon –––––– 2B90.2Z Malignant neoplasm of transverse colon, unspecified –––––– 2B90.30 Adenocarcinoma of sigmoid colon –––––– 2B90.3Y Other specified malignant neoplasm of sigmoid colon –––––– 2B90.3Z Malignant neoplasm of sigmoid colon, unspecified –––– 2B91 Malignant neoplasms of rectosigmoid junction ––––– 2B91.0 Adenocarcinoma of rectosigmoid junction ––––– 2B91.Y Other specified malignant neoplasms of rectosigmoid junction ––––– 2B91.Z Malignant neoplasms of rectosigmoid junction, unspecified –––– 2B92 Malignant neoplasms of rectum ––––– 2B92.0 Adenocarcinomas of rectum ––––– 2B92.1 Neuroendocrine neoplasms of rectum ––––– 2B92.Y Other specified malignant neoplasms of rectum ––––– 2B92.Z Malignant neoplasms of rectum, unspecified –––– 2B93 Malignant neoplasms of large intestine, site unspecified ––––– 2B93.0 Adenocarcinoma of large intestine, site unspecified ––––– 2B93.Y Other specified malignant neoplasms of large intestine, site unspecified ––––– 2B93.Z Malignant neoplasms of large intestine, site and type unspecified –––– 2B9Y Other specified malignant neoplasms of large intestine ––– 2C00 Malignant neoplasms of anus or anal canal –––– 2C00.0 Adenocarcinoma of anus or anal canal –––– 2C00.1 Melanoma of anus or anal canal –––– 2C00.2 Neuroendocrine neoplasm of anus or anal canal –––– 2C00.3 Squamous cell carcinoma of anus or anal canal –––– 2C00.Y Other specified malignant neoplasms of anus and anal canal –––– 2C00.Z Malignant neoplasms of anus or anal canal, unspecified ––– 2C0Y Other specified malignant neoplasms of intestine ––– 2C0Z Malignant neoplasms of intestine, unspecified –– 2C10 Malignant neoplasm of pancreas ––– 2C10.0 Adenocarcinoma of pancreas ––– 2C10.1 Neuroendocrine neoplasms of pancreas ––– 2C10.Y Other specified malignant neoplasms of pancreas ––– 2C10.Z Malignant neoplasm of pancreas, unspecified –– 2C11 Malignant neoplasms of other or ill-defined digestive organs ––– 2C11.0 Adenocarcinoma of other or ill-defined digestive organs ––– 2C11.1 Mucinous carcinoma of other or ill-defined digestive organs ––– 2C11.2 Other specified malignant neoplasms of other or ill-defined digestive organs ––– 2C11.Z Malignant neoplasms of other or ill-defined digestive organs, unspecified –– 2C12 Malignant neoplasms of liver or intrahepatic bile ducts ––– 2C12.0 Malignant neoplasm of liver ––– 2C12.1 Malignant neoplasm of intrahepatic bile ducts –––– 2C12.00 Combined hepatocellular-cholangiocarcinoma –––– 2C12.01 Hepatoblastoma –––– 2C12.02 Hepatocellular carcinoma of liver –––– 2C12.03 Mesothelial carcinoma of liver –––– 2C12.0Y Other specified malignant neoplasm of liver –––– 2C12.0Z Malignant neoplasm of liver, unspecified –––– 2C12.10 Intrahepatic cholangiocarcinoma –––– 2C12.1Y Other specified malignant neoplasms of intrahepatic bile ducts –––– 2C12.1Z Malignant neoplasm of intrahepatic bile ducts, unspecified –– 2C13 Malignant neoplasms of gallbladder ––– 2C13.0 Adenocarcinoma of the gallbladder ––– 2C13.Y Other specified malignant neoplasm of gallbladder ––– 2C13.Z Malignant neoplasms of gallbladder, unspecified –– 2C14 Malignant neoplasms of proximal biliary tract, cystic duct ––– 2C14.0 Adenocarcinoma of proximal biliary tract, cystic duct ––– 2C14.1 Mucinous cystic neoplasm with associated invasive carcinoma of cystic duct ––– 2C14.2 Neuroendocrine neoplasms of cystic duct ––– 2C14.Y Other specified malignant neoplasms of biliary tract, cystic duct ––– 2C14.Z Malignant neoplasms of proximal biliary tract, cystic duct, unspecified –– 2C15 Malignant neoplasms of biliary tract, distal bile duct ––– 2C15.0 Adenocarcinoma of biliary tract, distal bile duct ––– 2C15.1 Mucinous cystic neoplasm with associated invasive carcinoma of distal bile duct ––– 2C15.2 Neuroendocrine neoplasms of distal bile duct ––– 2C15.Y Other specified malignant neoplasms of biliary tract, distal bile duct ––– 2C15.Z Malignant neoplasms of biliary tract, distal bile duct, unspecified –– 2C16 Malignant neoplasms of ampulla of Vater ––– 2C16.0 Adenocarcinoma of ampulla of Vater ––– 2C16.1 Neuroendocrine neoplasms of ampulla of Vater ––– 2C16.Y Other specified malignant neoplasms of ampulla of Vater ––– 2C16.Z Malignant neoplasms of ampulla of Vater, unspecified –– 2C17 Malignant neoplasms of other or unspecified parts of biliary tract ––– 2C17.0 Adenocarcinoma of other or unspecified parts of biliary tract ––– 2C17.1 Mucinous cystic neoplasm with associated invasive carcinoma of other or unspecified parts of biliary tract ––– 2C17.2 Neuroendocrine neoplasms of other or unspecified parts of biliary tract ––– 2C17.Y Other specified malignant neoplasms of overlapping lesion of biliary tract ––– 2C17.Z Malignant neoplasms of other or unspecified parts of biliary tract, unspecified –– 2C18 Malignant neoplasms of perihilar bile duct ––– 2C18.0 Hilar cholangiocarcinoma ––– 2C18.1 Mucinous cystic neoplasm with associated invasive carcinoma of perihilar bile duct ––– 2C18.2 Neuroendocrine neoplasm of perihilar bile duct ––– 2C18.Y Other specified malignant neoplasms of perihilar bile duct ––– 2C18.Z Malignant neoplasms of perihilar bile duct, unspecified –– 2C1Z Malignant neoplasms of digestive organs, unspecified –– 2C20 Malignant neoplasms of nasal cavity ––– 2C20.0 Adenocarcinoma of nasal cavity ––– 2C20.1 Malignant neuroepitheliomatous neoplasm of nasal cavity ––– 2C20.2 Melanoma of nasal cavity ––– 2C20.3 Olfactory neuroblastoma ––– 2C20.4 Squamous cell carcinoma of nasal cavity ––– 2C20.Y Other specified malignant neoplasm of nasal cavity ––– 2C20.Z Malignant neoplasms of nasal cavity, unspecified –– 2C21 Malignant neoplasms of middle ear ––– 2C21.0 Adenocarcinoma of middle ear ––– 2C21.1 Squamous cell carcinoma of middle ear ––– 2C21.2 Unspecified malignant epithelial neoplasm of middle ear ––– 2C21.Y Other specified malignant neoplasm of middle ear ––– 2C21.Z Malignant neoplasms of middle ear, unspecified –– 2C22 Malignant neoplasms of accessory sinuses ––– 2C22.0 Adenocarcinoma of accessory sinuses ––– 2C22.1 Squamous cell carcinoma of accessory sinuses ––– 2C22.2 Malignant epithelial neoplasms of accessory sinuses, unspecified type ––– 2C22.3 Melanomas of accessory sinuses ––– 2C22.Y Other specified malignant neoplasms of accessory sinuses ––– 2C22.Z Malignant neoplasms of accessory sinuses, unspecified –––– 2C22.10 Squamous cell carcinoma of sphenoidal sinus –––– 2C22.1Y Squamous cell carcinoma of other specified accessory sinuses –– 2C23 Malignant neoplasms of larynx ––– 2C23.1 Malignant neoplasms of glottis of larynx ––– 2C23.2 Malignant neoplasms of supraglottis of larynx ––– 2C23.3 Malignant neoplasms of subglottis of larynx ––– 2C23.4 Malignant neoplasm of laryngeal cartilage ––– 2C23.5 Malignant neoplasm of overlapping lesion of larynx ––– 2C23.Z Malignant neoplasms of larynx, unspecified –––– 2C23.10 Squamous cell carcinoma of larynx, glottis –––– 2C23.1Y Other specified malignant neoplasms of larynx, glottis –––– 2C23.20 Squamous cell carcinoma of larynx, supraglottis –––– 2C23.2Y Other specified malignant neoplasms of larynx, supraglottis –––– 2C23.30 Squamous cell carcinoma of larynx, subglottis –––– 2C23.31 Adenocarcinoma of larynx, subglottis –––– 2C23.3Y Other specified malignant neoplasms of larynx, subglottis –– 2C24 Malignant neoplasms of trachea ––– 2C24.0 Adenocarcinoma of trachea ––– 2C24.1 Squamous cell carcinoma of trachea ––– 2C24.2 Malignant epithelial neoplasms of trachea, unspecified type ––– 2C24.Y Other specified malignant neoplasms of trachea ––– 2C24.Z Malignant neoplasms of trachea, unspecified –– 2C25 Malignant neoplasms of bronchus or lung ––– 2C25.0 Adenocarcinoma of bronchus or lung ––– 2C25.1 Small cell carcinoma of bronchus or lung ––– 2C25.2 Squamous cell carcinoma of bronchus or lung ––– 2C25.3 Large cell carcinoma of bronchus or lung ––– 2C25.4 Carcinoid or other malignant neuroendocrine neoplasms of bronchus or lung ––– 2C25.5 Unspecified malignant epithelial neoplasm of bronchus or lung ––– 2C25.Y Other specified malignant neoplasms of bronchus or lung ––– 2C25.Z Malignant neoplasms of bronchus or lung, unspecified –– 2C26 Malignant neoplasms of the pleura ––– 2C26.0 Mesothelioma of pleura ––– 2C26.Y Other specified malignant neoplasms of the pleura ––– 2C26.Z Malignant neoplasms of the pleura, unspecified –– 2C27 Malignant neoplasms of thymus ––– 2C27.0 Carcinoma of thymus ––– 2C27.1 Carcinoid tumour or other neuroendocrine neoplasms of thymus ––– 2C27.2 Malignant thymoma ––– 2C27.Y Other specified malignant neoplasms of thymus ––– 2C27.Z Malignant neoplasms of thymus, unspecified –– 2C28 Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.0 Malignant germ cell neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.1 Other specified malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura ––– 2C28.Z Malignant neoplasms of heart, mediastinum or non-mesothelioma of pleura, unspecified –– 2C29 Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.0 Squamous cell carcinomas of other and ill-defined sites in the respiratory system and intrathoracic organs ––– 2C29.1 Other specified malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs ––– 2C29.Z Malignant neoplasms of other or ill-defined sites in the respiratory system or intrathoracic organs, unspecified –– 2C2Y Other specified malignant neoplasms of middle ear, respiratory or intrathoracic organs –– 2C2Z Malignant neoplasms of middle ear, respiratory or intrathoracic organs, unspecified –– 2C30 Melanoma of skin ––– 2C30.0 Superficial spreading melanoma, primary ––– 2C30.1 Nodular melanoma, primary ––– 2C30.2 Lentigo maligna melanoma, primary ––– 2C30.3 Acral lentiginous melanoma, primary ––– 2C30.Y Other specified melanoma of skin ––– 2C30.Z Melanoma of skin, unspecified –– 2C31 Squamous cell carcinoma of skin ––– 2C31.0 Verrucous squamous cell carcinoma of skin ––– 2C31.1 Keratoacanthoma ––– 2C31.Z Cutaneous squamous cell carcinoma –– 2C32 Basal cell carcinoma of skin ––– 2C32.0 Nodular basal cell carcinoma of skin ––– 2C32.1 Sclerosing basal cell carcinoma of skin ––– 2C32.2 Superficial basal cell carcinoma of skin ––– 2C32.Y Other specified basal cell carcinoma of skin ––– 2C32.Z Basal cell carcinoma of skin, unspecified –– 2C33 Adnexal carcinoma of skin –– 2C34 Cutaneous neuroendocrine carcinoma –– 2C35 Cutaneous sarcoma –– 2C3Y Other specified malignant neoplasms of skin –– 2C3Z Malignant neoplasm of skin of unknown or unspecified type –– 2C40 Malignant neuroepitheliomatous neoplasms of peripheral nerves or autonomic nervous system –– 2C41 Malignant perineurioma –– 2C4Y Other specified malignant neoplasms of peripheral nerves and autonomic nervous system –– 2C4Z Malignant neoplasms of peripheral nerves or autonomic nervous system, unspecified –– 2C50 Malignant neoplasms of retroperitoneum ––– 2C50.0 Cystic, mucinous or serous carcinoma of retroperitoneum ––– 2C50.Y Other specified malignant neoplasms of retroperitoneum ––– 2C50.Z Malignant neoplasms of retroperitoneum, unspecified –– 2C51 Malignant neoplasms of peritoneum ––– 2C51.0 Adenocarcinomas of peritoneum ––– 2C51.1 Cystic, mucinous or serous carcinoma of peritoneum ––– 2C51.2 Mesotheliomas of peritoneum ––– 2C51.Y Other specified malignant neoplasms of peritoneum ––– 2C51.Z Malignant neoplasms of peritoneum, unspecified –––– 2C51.20 Mesothelioma of mesocolon –––– 2C51.21 Mesothelioma of mesentery –––– 2C51.2Y Mesotheliomas of other specified sites of peritoneum –––– 2C51.2Z Mesotheliomas of peritoneum, site unspecified –– 2C52 Malignant neoplasms of omentum ––– 2C52.0 Cystic, mucinous or serous carcinoma of omentum ––– 2C52.Y Other specified malignant neoplasms of omentum ––– 2C52.Z Malignant neoplasms of omentum, unspecified –– 2C53 Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.0 Adenocarcinoma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.1 Mesothelioma involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Y Other specified malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum ––– 2C53.Z Malignant neoplasm involving overlapping sites of retroperitoneum, peritoneum or omentum, unspecified –– 2C5Y Other specified malignant neoplasms of retroperitoneum, peritoneum or omentum –– 2C5Z Malignant neoplasms of retroperitoneum, peritoneum or omentum, unspecified –– 2C60 Carcinoma of breast, specialised type –– 2C61 Invasive carcinoma of breast ––– 2C61.0 Invasive ductal carcinoma of breast ––– 2C61.1 Invasive lobular carcinoma of breast ––– 2C61.2 Invasive pleomorphic lobular carcinoma of breast ––– 2C61.3 Invasive carcinoma of breast with mixed ductal and lobular features ––– 2C61.4 Invasive carcinoma of breast, unidentifiable type –– 2C62 Inflammatory carcinoma of breast –– 2C63 Malignant phyllodes tumour of breast –– 2C64 Solid papillary carcinoma of breast with evidence of invasion –– 2C65 Hereditary breast and ovarian cancer syndrome –– 2C6Y Other specified malignant neoplasms of breast –– 2C6Z Malignant neoplasms of breast, unspecified –– 2C70 Malignant neoplasms of vulva ––– 2C70.0 Basal cell carcinoma of vulva ––– 2C70.1 Melanoma of vulva ––– 2C70.2 Squamous cell carcinoma of vulva ––– 2C70.Y Other specified malignant neoplasms of vulva ––– 2C70.Z Malignant neoplasms of vulva, unspecified –– 2C71 Malignant neoplasms of vagina ––– 2C71.0 Adenocarcinoma of vagina ––– 2C71.1 Melanoma of vagina ––– 2C71.2 Squamous cell carcinoma of vagina ––– 2C71.Y Other specified malignant neoplasms of vagina ––– 2C71.Z Malignant neoplasms of vagina, unspecified –– 2C72 Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa ––– 2C72.0 Adenocarcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.1 Mucinous or serous carcinoma of uterine ligament, parametrium, or uterine adnexa ––– 2C72.3 Carcinosarcomas of uterine ligament, parametrium, or uterine adnexa ––– 2C72.Y Other specified malignant neoplasms of uterine ligament, parametrium, and uterine adnexa ––– 2C72.Z Malignant neoplasms of uterine ligament, parametrium, or uterine adnexa, unspecified –– 2C73 Malignant neoplasms of ovary ––– 2C73.0 Carcinomas of ovary ––– 2C73.1 Dysgerminoma of ovary ––– 2C73.2 Granulosa cell malignant tumour of ovary ––– 2C73.3 Malignant teratoma of ovary ––– 2C73.4 Serous cystadenoma, borderline malignancy of ovary ––– 2C73.5 Endodermal sinus tumour, unspecified site, female ––– 2C73.Y Other specified malignant neoplasms of the ovary ––– 2C73.Z Malignant neoplasms of ovary, unspecified –––– 2C73.00 Clear cell adenocarcinoma of ovary –––– 2C73.01 Endometrioid adenocarcinoma of ovary –––– 2C73.02 Low grade serous adenocarcinoma of ovary –––– 2C73.03 High grade serous adenocarcinoma of ovary –––– 2C73.04 Mucinous adenocarcinoma of ovary –––– 2C73.0Y Other specified carcinomas of ovary –––– 2C73.0Z Carcinomas of ovary, unspecified –– 2C74 Malignant neoplasms of fallopian tube ––– 2C74.0 Adenocarcinoma of fallopian tube ––– 2C74.Y Other specified malignant neoplasms of fallopian tube ––– 2C74.Z Malignant neoplasms of fallopian tube, unspecified –– 2C75 Malignant neoplasms of placenta ––– 2C75.0 Malignant trophoblastic neoplasms of placenta ––– 2C75.Y Other specified malignant neoplasms of placenta ––– 2C75.Z Malignant neoplasms of placenta, unspecified –– 2C76 Malignant neoplasms of corpus uteri ––– 2C76.0 Endometrial endometrioid adenocarcinoma ––– 2C76.1 Endometrial mucinous adenocarcinoma ––– 2C76.2 Endometrial clear cell adenocarcinoma ––– 2C76.3 Endometrial serous adenocarcinoma ––– 2C76.4 Endometrial mixed adenocarcinoma ––– 2C76.Y Other specified malignant neoplasms of corpus uteri ––– 2C76.Z Malignant neoplasms of corpus uteri, unspecified –––– 2C76.40 Endometrial squamous cell carcinoma –––– 2C76.41 Endometrial small cell carcinoma –––– 2C76.42 Endometrial undifferentiated carcinoma –––– 2C76.43 Carcinosarcoma of uterus –––– 2C76.4Z Endometrial mixed adenocarcinoma, unspecified –– 2C77 Malignant neoplasms of cervix uteri ––– 2C77.0 Squamous cell carcinoma of cervix uteri ––– 2C77.1 Adenocarcinoma of cervix uteri ––– 2C77.2 Adenosquamous carcinoma of cervix uteri ––– 2C77.3 Neuroendocrine carcinoma of cervix uteri ––– 2C77.Y Other specified malignant neoplasms of cervix uteri ––– 2C77.Z Malignant neoplasms of cervix uteri, unspecified –– 2C78 Malignant neoplasms of uterus, part not specified –– 2C79 Malignant neoplasm involving overlapping sites of female genital organs –– 2C7Y Other specified malignant neoplasms of female genital organs –– 2C7Z Malignant neoplasms of female genital organs, unspecified –– 2C80 Malignant neoplasms of testis ––– 2C80.2 Germ cell tumour of testis ––– 2C80.Y Other specified malignant neoplasms of testis ––– 2C80.Z Malignant neoplasms of testis, unspecified –– 2C81 Malignant neoplasms of penis ––– 2C81.0 Squamous cell carcinoma of penis ––– 2C81.1 Melanoma of penis ––– 2C81.Y Other specified malignant neoplasm of penis ––– 2C81.Z Malignant neoplasms of penis, unspecified –– 2C82 Malignant neoplasms of prostate ––– 2C82.0 Adenocarcinoma of prostate ––– 2C82.Y Other specified malignant neoplasms of prostate ––– 2C82.Z Malignant neoplasms of prostate, unspecified –– 2C83 Malignant neoplasms of scrotum ––– 2C83.0 Squamous cell carcinoma of scrotum ––– 2C83.Y Other specified malignant neoplasms of scrotum ––– 2C83.Z Malignant neoplasms of scrotum, unspecified –– 2C84 Malignant neoplasms of other specified male genital organs –– 2C8Z Malignant neoplasms of male genital organs, unspecified –– 2C90 Malignant neoplasms of kidney, except renal pelvis ––– 2C90.0 Renal cell carcinoma of kidney, except renal pelvis ––– 2C90.Y Other specified malignant neoplasms of kidney, except renal pelvis ––– 2C90.Z Malignant neoplasms of kidney, except renal pelvis, unspecified –– 2C91 Malignant neoplasms of renal pelvis ––– 2C91.0 Urothelial carcinoma of renal pelvis ––– 2C91.Y Other specified malignant neoplasms of renal pelvis ––– 2C91.Z Malignant neoplasms of renal pelvis, unspecified –– 2C92 Malignant neoplasms of ureter ––– 2C92.0 Urothelial carcinoma of ureter ––– 2C92.Y Other specified malignant neoplasms of ureter ––– 2C92.Z Malignant neoplasms of ureter, unspecified –– 2C93 Malignant neoplasms of urethra or paraurethral gland ––– 2C93.0 Adenocarcinoma of urethra or paraurethral gland ––– 2C93.1 Squamous cell carcinoma of urethra or paraurethral gland ––– 2C93.2 Urothelial carcinoma of urethra or paraurethral gland ––– 2C93.Y Other specified malignant neoplasms of urethra and paraurethral gland ––– 2C93.Z Malignant neoplasms of urethra or paraurethral gland, unspecified –– 2C94 Malignant neoplasms of bladder ––– 2C94.0 Adenocarcinoma of urinary bladder ––– 2C94.1 Squamous cell carcinoma of urinary bladder ––– 2C94.2 Urothelial carcinoma of bladder ––– 2C94.Y Other specified malignant neoplasms of bladder ––– 2C94.Z Malignant neoplasms of bladder, unspecified –– 2C95 Malignant neoplasm involving overlapping sites of urinary organs ––– 2C95.0 Adenocarcinoma involving overlapping sites of urinary organs ––– 2C95.1 Squamous cell carcinomas involving overlapping sites of urinary organs ––– 2C95.2 Urothelial carcinoma involving overlapping sites of urinary organs ––– 2C95.Y Other specified malignant neoplasms of overlapping lesion of urinary organs ––– 2C95.Z Malignant neoplasm involving overlapping sites of urinary organs, unspecified –– 2C9Y Other specified malignant neoplasms of urinary tract –– 2C9Z Malignant neoplasms of urinary tract, unspecified –– 2D00 Malignant neoplasm of conjunctiva ––– 2D00.0 Melanoma of conjunctiva ––– 2D00.1 Malignant neoplasm of caruncle ––– 2D00.2 Squamous cell carcinoma of conjunctiva ––– 2D00.Y Other specified malignant neoplasm of conjunctiva ––– 2D00.Z Malignant neoplasm of conjunctiva, unspecified –– 2D01 Malignant neoplasm of cornea ––– 2D01.0 Melanoma of cornea ––– 2D01.1 Squamous cell carcinoma of cornea ––– 2D01.Y Other specified malignant neoplasms of cornea ––– 2D01.Z Malignant neoplasm of cornea, unspecified –– 2D02 Malignant neoplasm of retina ––– 2D02.0 Adenocarcinoma of retinal pigment epithelium ––– 2D02.1 Malignant neuroepithelial tumours of retina ––– 2D02.2 Retinoblastoma ––– 2D02.Y Other specified malignant neoplasm of retina ––– 2D02.Z Malignant neoplasm of retina, unspecified –– 2D03 Malignant neoplasm of lacrimal apparatus ––– 2D03.0 Adenocarcinoma of the lacrimal apparatus ––– 2D03.1 Mucoepidermoid carcinoma of lacrimal apparatus ––– 2D03.2 Squamous cell carcinoma of the lacrimal apparatus ––– 2D03.Y Other specified malignant neoplasm of lacrimal apparatus ––– 2D03.Z Malignant neoplasm of lacrimal apparatus, unspecified –– 2D04 Malignant neoplasm of orbit –– 2D05 Malignant neoplasm of choroid ––– 2D05.0 Melanoma of choroid ––– 2D05.Y Other specified malignant neoplasm of choroid ––– 2D05.Z Malignant neoplasm of choroid, unspecified –– 2D06 Malignant neoplasm of ciliary body ––– 2D06.0 Adenocarcinoma of ciliary epithelium ––– 2D06.1 Malignant medulloepithelioma of ciliary body ––– 2D06.3 Malignant neuroepithelial tumours of ciliary body ––– 2D06.4 Melanoma of ciliary body ––– 2D06.Y Other specified malignant neoplasm of ciliary body ––– 2D06.Z Malignant neoplasm of ciliary body, unspecified –– 2D07 Malignant neoplasm of iris ––– 2D07.0 Adenocarcinoma of iris epithelium ––– 2D07.1 Malignant neuroepithelial tumours of iris ––– 2D07.2 Melanoma of iris ––– 2D07.Y Other specified malignant neoplasm of iris ––– 2D07.Z Malignant neoplasm of iris, unspecified –– 2D0Y Other specified malignant neoplasms of eye and ocular adnexa –– 2D0Z Malignant neoplasms of eye or ocular adnexa, unspecified –– 2D10 Malignant neoplasms of thyroid gland ––– 2D10.0 Follicular carcinoma of thyroid gland ––– 2D10.1 Papillary carcinoma of thyroid gland ––– 2D10.2 Poorly differentiated carcinoma of thyroid gland ––– 2D10.3 Undifferentiated carcinoma of thyroid gland ––– 2D10.4 Medullary carcinoma of thyroid gland ––– 2D10.Y Other specified malignant neoplasms of thyroid gland ––– 2D10.Z Malignant neoplasms of thyroid gland, unspecified –– 2D11 Malignant neoplasms of adrenal gland ––– 2D11.0 Adenocarcinoma of adrenal gland ––– 2D11.1 Malignant phaeochromocytoma of adrenal gland ––– 2D11.2 Neuroblastoma of adrenal gland ––– 2D11.Y Other specified malignant neoplasms of adrenal gland ––– 2D11.Z Malignant neoplasms of adrenal gland, unspecified –– 2D12 Malignant neoplasms of other endocrine glands or related structures ––– 2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type ––– 2D12.1 Adenocarcinoma of other endocrine glands or related structures ––– 2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures ––– 2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified –– 2D1Z Malignant neoplasms of endocrine glands, unspecified – 2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues – 2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified – 2D40 Adenocarcinoma of unspecified site – 2D41 Unspecified carcinoma of unspecified site – 2D42 Malignant neoplasms of ill-defined sites – 2D43 Malignant neoplasms of independent, multiple primary sites – 2D44 Malignant neoplasm, primary site unknown, so stated – 2D4Y Other specified malignant neoplasms of unspecified primary sites – 2D4Z Unspecified malignant neoplasms of unspecified sites – 2D50 Malignant neoplasm metastasis in brain – 2D51 Malignant neoplasm metastasis in meninges – 2D52 Malignant neoplasm metastasis in spinal cord, cranial nerves or remaining parts of central nervous system –– 2D60 Malignant neoplasm metastasis in lymph node of a single region ––– 2D60.0 Malignant neoplasm metastasis in lymph nodes of head, face or neck ––– 2D60.1 Malignant neoplasm metastasis in intrathoracic lymph nodes ––– 2D60.2 Malignant neoplasm metastasis in intra-abdominal lymph nodes ––– 2D60.3 Malignant neoplasm metastasis in axillary lymph nodes ––– 2D60.4 Malignant neoplasm metastasis in inguinal lymph nodes ––– 2D60.5 Malignant neoplasm metastasis in intrapelvic lymph nodes ––– 2D60.Y Other specified malignant neoplasm metastasis in lymph node of a single region ––– 2D60.Z Malignant neoplasm metastasis in lymph node of a single region, unspecified –– 2D61 Malignant neoplasm metastases in lymph nodes of multiple regions –– 2D6Z Metastatic malignant neoplasm to unspecified lymph node –– 2D70 Malignant neoplasm metastasis in lung –– 2D71 Malignant neoplasm metastasis in mediastinum –– 2D72 Malignant neoplasm metastasis in pleura –– 2D73 Malignant neoplasm metastasis in upper respiratory tract organs –– 2D7Y Malignant neoplasm metastasis in other specified thoracic organs –– 2D7Z Malignant neoplasm metastasis in thoracic or respiratory organs, unspecified –– 2D80 Malignant neoplasm metastasis in liver or intrahepatic bile duct ––– 2D80.0 Malignant neoplasm metastasis in liver ––– 2D80.1 Malignant neoplasm metastasis in intrahepatic bile duct –– 2D81 Malignant neoplasm metastasis in pancreas –– 2D82 Malignant neoplasm metastasis in extrahepatic bile ducts –– 2D83 Malignant neoplasm metastasis in ampulla of Vater –– 2D84 Malignant neoplasm metastasis in the small intestine –– 2D85 Malignant neoplasm metastasis in large intestine –– 2D86 Malignant neoplasm metastasis in anus –– 2D8Y Malignant neoplasm metastasis in other specified digestive system organ –– 2D8Z Malignant neoplasm metastasis in unspecified digestive system organ –– 2D90 Malignant neoplasm metastasis in retroperitoneum –– 2D91 Malignant neoplasm metastasis in peritoneum –– 2E00 Malignant neoplasm metastasis in kidney or renal pelvis –– 2E01 Malignant neoplasm metastasis in bladder –– 2E02 Malignant neoplasm metastasis in other or unspecified urinary system organs –– 2E03 Malignant neoplasm metastasis in bone or bone marrow –– 2E04 Malignant neoplasm metastasis in soft tissue –– 2E05 Malignant neoplasm metastasis in female reproductive system ––– 2E05.0 Malignant neoplasm metastasis in ovary ––– 2E05.Y Malignant neoplasm metastasis in other female reproductive system organs ––– 2E05.Z Malignant neoplasm metastasis in female reproductive system, unspecified –– 2E06 Malignant neoplasm metastasis in male genital organs –– 2E07 Malignant neoplasm metastasis in adrenal gland –– 2E08 Metastatic malignant neoplasm involving skin –– 2E09 Malignant neoplasm metastasis in peripheral nervous system –– 2E0Y Malignant neoplasm metastasis in other specified sites – 2E2Z Malignant neoplasm metastasis, unspecified 2E60 Carcinoma in situ of oral cavity, oesophagus or stomach – 2E60.0 Carcinoma in situ of lip, oral cavity or pharynx – 2E60.1 Carcinoma in situ of oesophagus – 2E60.2 Carcinoma in situ of stomach 2E61 Carcinoma in situ of other or unspecified digestive organs – 2E61.0 Carcinoma in situ of colon – 2E61.1 Carcinoma in situ of rectum – 2E61.2 Carcinoma in situ of anal canal – 2E61.3 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater – 2E61.Y Carcinoma in situ of other specified digestive organs – 2E61.Z Carcinoma in situ of unspecified digestive organs 2E62 Carcinoma in situ of middle ear or respiratory system – 2E62.0 Carcinoma in situ of larynx – 2E62.1 Carcinoma in situ of trachea – 2E62.2 Carcinoma in situ of bronchus or lung – 2E62.Y Carcinoma in situ of other specified sites of middle ear and respiratory system – 2E62.Z Carcinoma in situ of unspecified sites of middle ear and respiratory system 2E63 Melanoma in situ neoplasms – 2E63.0 Melanoma in situ of skin – 2E63.1 Melanoma in situ of conjunctiva – 2E63.Y Melanoma in situ neoplasms, other specified site – 2E63.Z Melanoma in situ neoplasms, unspecified site –– 2E63.00 Lentigo maligna –– 2E63.0Z Melanoma in situ of skin, unspecified 2E64 Carcinoma in situ of skin – 2E64.0 Intraepidermal squamous cell carcinoma – 2E64.1 Extramammary Paget disease of skin – 2E64.2 Carcinoma in situ of anal margin or perianal skin – 2E64.Y Other specified carcinoma in situ of skin – 2E64.Z Carcinoma in situ of skin, unspecified –– 2E64.00 Bowen disease of skin –– 2E64.01 Actinic intraepidermal squamous cell carcinoma –– 2E64.0Y Other specified intraepidermal squamous cell carcinoma –– 2E64.0Z Intraepidermal squamous cell carcinoma, unspecified 2E65 Carcinoma in situ of breast – 2E65.0 Lobular carcinoma in situ of breast – 2E65.1 Lobular carcinoma in situ of breast, pleomorphic subtype – 2E65.2 Ductal carcinoma in situ of breast – 2E65.3 Ductal carcinoma in situ of breast, comedo subtype – 2E65.4 Mixed ductal and lobular carcinoma in situ of breast – 2E65.5 Paget disease of nipple – 2E65.Y Other specified carcinoma in situ of breast – 2E65.Z Carcinoma in situ of breast, unspecified 2E66 Carcinoma in situ of cervix uteri – 2E66.2 High grade squamous intraepithelial lesion of cervix uteri – 2E66.Y Other specified carcinoma in situ of cervix uteri – 2E66.Z Carcinoma in situ of cervix uteri, unspecified 2E67 Carcinoma in situ of other or unspecified genital organs – 2E67.0 Carcinoma in situ of endometrium – 2E67.1 Carcinoma in situ of vulva – 2E67.2 Carcinoma in situ of vagina – 2E67.3 Carcinoma in situ of other or unspecified female genital organs – 2E67.4 Carcinoma in situ of penis – 2E67.5 High grade intraepithelial lesion of prostate – 2E67.6 Carcinoma in situ of other or unspecified male genital organs –– 2E67.11 Vulvar Paget disease –– 2E67.12 Vulvar intraepithelial neoplasia, HPV-independent –– 2E67.13 High grade squamous intraepithelial lesion of vulva, HPV-associated –– 2E67.22 High grade squamous intraepithelial lesion of vagina –– 2E67.2Y Other specified carcinoma in situ of vagina –– 2E67.2Z Carcinoma in situ of vagina, unspecified –– 2E67.40 Squamous cell carcinoma in situ of skin of penis –– 2E67.41 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis 2E68 Carcinoma in situ of bladder 2E69 Carcinoma in situ of other or unspecified urinary organs 2E6A Carcinoma in situ of the eye or ocular adnexa – 2E6A.0 Carcinoma in situ of the conjunctiva – 2E6A.1 Carcinoma in situ of the cornea – 2E6A.Y Carcinoma in situ of other and unspecified part of the eye and adnexa 2E6B Carcinoma in situ of thyroid and other endocrine glands 2E6Y Carcinoma in situ of other specified site 2E6Z Carcinoma in situ of unspecified site – 2E80 Benign lipomatous neoplasm –– 2E80.0 Lipoma –– 2E80.1 Lipoblastoma –– 2E80.Y Other specified benign lipomatous neoplasm –– 2E80.Z Benign lipomatous neoplasm, unspecified ––– 2E80.00 Superficial subcutaneous lipoma ––– 2E80.01 Deep subfascial lipoma ––– 2E80.02 Deep internal or visceral lipoma ––– 2E80.0Y Lipoma, other specified site ––– 2E80.0Z Lipoma, unspecified site – 2E81 Benign vascular neoplasms –– 2E81.0 Neoplastic haemangioma –– 2E81.1 Benign lymphatic neoplasms –– 2E81.2 Benign vascular neoplasms of infancy and childhood –– 2E81.Y Other specified benign vascular neoplasms –– 2E81.Z Benign vascular neoplasms, unspecified ––– 2E81.00 Umbilical cord haemangioma ––– 2E81.01 Conjunctival haemangioma or haemolymphangioma ––– 2E81.0Y Neoplastic haemangioma of other specified site ––– 2E81.0Z Neoplastic haemangioma, unspecified site ––– 2E81.10 Disseminated lymphangiomatosis ––– 2E81.11 Acquired progressive lymphangioma ––– 2E81.1Y Other specified benign lymphatic neoplasms ––– 2E81.1Z Benign lymphatic neoplasms, unspecified ––– 2E81.20 Focal infantile haemangioma ––– 2E81.21 Multifocal infantile haemangioma ––– 2E81.2Y Other specified benign vascular neoplasms of infancy and childhood ––– 2E81.2Z Benign vascular neoplasms of infancy and childhood, unspecified – 2E82 Benign chondrogenic tumours –– 2E82.0 Benign chondrogenic tumours of bone or articular cartilage of limbs –– 2E82.1 Benign chondrogenic tumours of bone or articular cartilage of other specified sites –– 2E82.Z Benign chondrogenic tumours, site unspecified – 2E83 Benign osteogenic tumours –– 2E83.0 Benign osteogenic tumours of bone or articular cartilage of skull or face –– 2E83.1 Benign osteogenic tumours of bone or articular cartilage of lower jaw –– 2E83.2 Benign osteogenic tumours of bone or articular cartilage of vertebral column –– 2E83.3 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle –– 2E83.4 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx –– 2E83.5 Benign osteogenic tumours of bone or articular cartilage of limbs –– 2E83.Y Benign osteogenic tumour of other specified site –– 2E83.Z Benign osteogenic tumour of unspecified site – 2E84 Benign fibrogenic or myofibrogenic tumour –– 2E84.0 Benign fibrogenic or myofibrogenic tumour of skin –– 2E84.Y Benign fibrogenic or myofibrogenic tumour of other specified sites –– 2E84.Z Benign fibrogenic or myofibrogenic tumour, site unknown – 2E85 Benign fibrohistiocytic tumour –– 2E85.0 Benign fibrohistiocytic tumour of soft tissues of limbs –– 2E85.1 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum –– 2E85.2 Benign fibrohistiocytic tumour of skin –– 2E85.Y Benign fibrohistiocytic tumour of other specified sites –– 2E85.Z Benign fibrohistiocytic tumour, site unspecified – 2E86 Benign smooth muscle or skeletal muscle tumour –– 2E86.0 Leiomyoma of uterus –– 2E86.1 Leiomyoma of other or unspecified sites –– 2E86.2 Rhabdomyoma –– 2E86.Y Other specified benign smooth muscle or skeletal muscle tumour –– 2E86.Z Benign smooth muscle or skeletal muscle tumour, unspecified – 2E87 Benign gastrointestinal stromal tumour – 2E88 Benign endometrial stromal nodule – 2E89 Benign mesenchymal tumours of uncertain differentiation –– 2E89.0 Benign tumours of uncertain differentiation, bone or cartilage –– 2E89.1 Benign tumours of uncertain differentiation, soft tissue –– 2E89.Y Benign mesenchymal tumours of uncertain differentiation of other specified site –– 2E89.Z Benign mesenchymal tumours of uncertain differentiation of unspecified site – 2E8A Other mixed or unspecified benign mesenchymal tumours – 2E8Y Other specified benign mesenchymal neoplasm – 2E8Z Benign mesenchymal neoplasms, unspecified – 2E90 Benign neoplasm of lip, oral cavity or pharynx –– 2E90.0 Benign neoplasm of lip –– 2E90.1 Benign neoplasm of tongue –– 2E90.2 Benign neoplasm of floor of mouth –– 2E90.3 Benign neoplasm of other or unspecified parts of mouth –– 2E90.4 Benign neoplasm of tonsil –– 2E90.5 Benign neoplasm of oropharynx –– 2E90.6 Benign neoplasm of nasopharynx –– 2E90.7 Benign neoplasm of hypopharynx –– 2E90.8 Benign neoplasm of pharynx, unspecified – 2E91 Benign neoplasm of major salivary glands –– 2E91.0 Benign neoplasm of parotid gland –– 2E91.1 Benign neoplasm of other specified major salivary glands –– 2E91.Z Benign neoplasm of unspecified major salivary glands – 2E92 Benign neoplasm of digestive organs –– 2E92.0 Benign neoplasm of oesophagus –– 2E92.1 Benign neoplasm of stomach –– 2E92.2 Benign neoplasm of duodenum –– 2E92.3 Benign neoplasm of other or unspecified parts of small intestine –– 2E92.4 Benign neoplasm of the large intestine –– 2E92.5 Benign neoplasm of anus or anal canal –– 2E92.6 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater –– 2E92.7 Benign neoplasm of liver or intrahepatic bile ducts –– 2E92.8 Benign neoplasm of pancreas –– 2E92.9 Benign neoplasm of endocrine pancreas –– 2E92.Y Benign neoplasm of other specified digestive organs –– 2E92.Z Benign neoplasm of unspecified digestive organs ––– 2E92.40 Polyposis syndrome ––– 2E92.4Y Other specified benign neoplasm of the large intestine ––– 2E92.4Z Benign neoplasm of the large intestine, unspecified –– 2F00 Benign neoplasm of middle ear or respiratory system ––– 2F00.0 Middle ear endocrine tumour ––– 2F00.1 Recurrent respiratory papillomatosis ––– 2F00.2 Laryngeal endocrine tumour ––– 2F00.Y Other specified benign neoplasm of middle ear or respiratory system ––– 2F00.Z Benign neoplasm of middle ear or respiratory system, unspecified –– 2F01 Benign neoplasm of intrathoracic organs –– 2F0Y Benign neoplasms of other specified respiratory and intrathoracic organs –– 2F0Z Benign neoplasms of unspecified respiratory and intrathoracic organs – 2F10 Benign neoplasm of mesothelial tissue –– 2F20 Benign cutaneous melanocytic neoplasms ––– 2F20.0 Common acquired melanocytic naevus ––– 2F20.1 Atypical melanocytic naevus ––– 2F20.2 Congenital melanocytic naevus ––– 2F20.3 Generalised eruptive melanocytic naevi ––– 2F20.Y Other specific types of melanocytic naevus ––– 2F20.Z Melanocytic naevus, unspecified –––– 2F20.00 Multiple benign melanocytic naevi –––– 2F20.0Y Other specified common acquired melanocytic naevus –––– 2F20.0Z Common acquired melanocytic naevus, unspecified –––– 2F20.20 Giant congenital melanocytic naevus –––– 2F20.2Y Other specified congenital melanocytic naevus –––– 2F20.2Z Congenital melanocytic naevus, unspecified –– 2F21 Benign keratinocytic acanthomas ––– 2F21.0 Seborrhoeic keratosis ––– 2F21.Y Other specified benign keratinocytic acanthomas –– 2F22 Benign neoplasms of epidermal appendages –– 2F23 Benign dermal fibrous or fibrohistiocytic neoplasms ––– 2F23.0 Dermatofibroma ––– 2F23.Y Other specified benign dermal fibrous or fibrohistiocytic neoplasms –– 2F24 Benign cutaneous neoplasms of neural or nerve sheath origin –– 2F25 Cherry angioma –– 2F26 Lobular capillary haemangioma –– 2F2Y Other specified benign cutaneous neoplasms –– 2F2Z Benign cutaneous neoplasm of unspecified type – 2F30 Benign neoplasm of breast –– 2F30.0 Tubular adenoma of breast –– 2F30.1 Lactating adenoma of breast –– 2F30.2 Intraductal papilloma of breast –– 2F30.3 Benign phyllodes tumour of breast –– 2F30.4 Fibromatosis of breast –– 2F30.5 Fibroadenoma of breast –– 2F30.6 Extensive adenomatosis of nipple –– 2F30.Y Other specified benign neoplasm of breast –– 2F30.Z Benign neoplasm of breast, unspecified – 2F31 Benign non-mesenchymal neoplasms of uterus –– 2F31.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri –– 2F31.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri –– 2F31.2 Benign non-mesenchymal neoplasms of uterus, other parts – 2F32 Benign neoplasm of ovary –– 2F32.0 Cystic teratoma –– 2F32.1 Ovarian fibroma –– 2F32.2 Meigs' syndrome –– 2F32.3 Serous ovarian cystadenoma –– 2F32.Y Other specified benign neoplasm of ovary –– 2F32.Z Benign neoplasm of ovary, unspecified – 2F33 Benign neoplasm of other or unspecified female genital organs – 2F34 Benign neoplasm of male genital organs – 2F35 Benign neoplasm of urinary organs – 2F36 Benign neoplasm of eye or ocular adnexa –– 2F36.0 Benign neoplasm of choroid –– 2F36.1 Benign neoplasm of iris –– 2F36.2 Benign neoplasm of ciliary body –– 2F36.3 Teratoma of orbit –– 2F36.4 Cysts of eyelid –– 2F36.Y Other specified benign neoplasm of eye or ocular adnexa –– 2F36.Z Benign neoplasm of eye or ocular adnexa, unspecified – 2F37 Benign neoplasm of endocrine glands –– 2F37.0 Non-secreting pituitary adenoma –– 2F37.Y Other specified benign neoplasm of endocrine glands –– 2F37.Z Benign neoplasm of endocrine glands, unspecified – 2F3Y Benign non-mesenchymal neoplasms of other specified site – 2F3Z Benign non-mesenchymal neoplasms of unspecified site 2F5Y Other specified benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2F5Z Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified 2F70 Neoplasms of uncertain behaviour of oral cavity or digestive organs – 2F70.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx – 2F70.1 Neoplasms of uncertain behaviour of stomach – 2F70.2 Neoplasms of uncertain behaviour of small intestine – 2F70.3 Neoplasms of uncertain behaviour of colon – 2F70.4 Neoplasms of uncertain behaviour of rectum – 2F70.5 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts – 2F70.Y Neoplasms of uncertain behaviour of oral cavity and digestive organs, other specified site – 2F70.Z Neoplasms of uncertain behaviour of oral cavity and digestive organs, unspecified site 2F71 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs – 2F71.0 Neoplasms of uncertain behaviour of thymus – 2F71.1 Neoplasms of uncertain behaviour of larynx – 2F71.2 Neoplasms of uncertain behaviour of pleura – 2F71.3 Neoplasms of uncertain behaviour of trachea, bronchus or lung – 2F71.4 Neoplasms of uncertain behaviour of mediastinum – 2F71.Y Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, other specified site – 2F71.Z Neoplasms of uncertain behaviour of middle ear, respiratory and intrathoracic organs, unspecified site 2F72 Neoplasms of uncertain behaviour of skin – 2F72.1 Spitzoid tumour of uncertain malignant potential – 2F72.2 Melanocytic naevus with severe melanocytic dysplasia – 2F72.Y Other specified neoplasms of uncertain behaviour of skin 2F73 Neoplasms of uncertain behaviour of retroperitoneum 2F74 Neoplasms of uncertain behaviour of peritoneum 2F75 Neoplasms of uncertain behaviour of breast 2F76 Neoplasms of uncertain behaviour of female genital organs 2F77 Neoplasms of uncertain behaviour of male genital organs 2F78 Neoplasms of uncertain behaviour of urinary organs 2F79 Neoplasms of uncertain behaviour of eye or ocular adnexa 2F7A Neoplasms of uncertain behaviour of endocrine glands – 2F7A.0 Multiple polyglandular tumours – 2F7A.Y Other specified neoplasms of uncertain behaviour of endocrine glands – 2F7A.Z Neoplasms of uncertain behaviour of endocrine glands, unspecified 2F7B Neoplasms of uncertain behaviour of bone or articular cartilage 2F7C Neoplasms of uncertain behaviour of connective or other soft tissue 2F7Y Neoplasms of uncertain behaviour of other specified site 2F7Z Neoplasms of uncertain behaviour of unspecified site 2F90 Neoplasms of unknown behaviour of oral cavity or digestive organs – 2F90.0 Neoplasms of unknown behaviour of colon – 2F90.1 Neoplasms of unknown behaviour of rectum – 2F90.Y Neoplasms of unknown behaviour of oral cavity and digestive organs, other specified site – 2F90.Z Neoplasms of unknown behaviour of oral cavity and digestive organs, unspecified site 2F91 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs – 2F91.0 Neoplasms of unknown behaviour of larynx – 2F91.1 Neoplasms of unknown behaviour of trachea, bronchus or lung – 2F91.Y Neoplasms of unknown behaviour of other specified respiratory organ, intrathoracic organ or middle ear – 2F91.Z Neoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ 2F92 Neoplasms of unknown behaviour of skin 2F93 Neoplasms of unknown behaviour of retroperitoneum 2F94 Neoplasms of unknown behaviour of peritoneum 2F95 Neoplasms of unknown behaviour of breast 2F96 Neoplasms of unknown behaviour of female genital organs 2F97 Neoplasms of unknown behaviour of male genital organs 2F98 Neoplasms of unknown behaviour of urinary organs 2F99 Neoplasms of unknown behaviour of eye or ocular adnexa 2F9A Neoplasms of unknown behaviour of endocrine glands 2F9B Neoplasms of unknown behaviour of bone or articular cartilage 2F9C Neoplasms of unknown behaviour of connective or other soft tissue 2F9Y Neoplasms of unknown behaviour of other specified site 2F9Z Neoplasms of unknown behaviour of unspecified site 4A00 Primary immunodeficiencies due to disorders of innate immunity – 4A00.0 Functional neutrophil defects – 4A00.1 Defects in the complement system – 4A00.2 Genetic susceptibility to particular pathogens – 4A00.3 Immunodeficiency with natural-killer cell deficiency – 4A00.Y Other specified primary immunodeficiencies due to disorders of innate immunity – 4A00.Z Primary immunodeficiencies due to disorders of innate immunity, unspecified –– 4A00.00 Neutrophil immunodeficiency syndrome –– 4A00.0Y Other specified functional neutrophil defects –– 4A00.0Z Functional neutrophil defects, unspecified –– 4A00.10 Immunodeficiency with an early component of complement deficiency –– 4A00.11 Immunodeficiency with a late component of complement deficiency –– 4A00.12 Immunodeficiency with factor B deficiency –– 4A00.13 Immunodeficiency with factor D anomaly –– 4A00.14 Hereditary angioedema –– 4A00.15 Acquired angioedema –– 4A00.1Y Other specified defects in the complement system –– 4A00.1Z Defects in the complement system, unspecified 4A01 Primary immunodeficiencies due to disorders of adaptive immunity – 4A01.0 Immunodeficiencies with predominantly antibody defects – 4A01.1 Combined immunodeficiencies – 4A01.2 Diseases of immune dysregulation – 4A01.3 Other well-defined immunodeficiency syndromes due to defects in adaptive immunity – 4A01.Z Primary immunodeficiencies due to disorders of adaptive immunity, unspecified –– 4A01.00 Hereditary agammaglobulinaemia with profoundly reduced or absent B cells –– 4A01.01 Immunodeficiencies with severe reduction in at least two serum immunoglobulin isotypes with normal or low numbers of B cells –– 4A01.02 Specific antibody deficiency with normal immunoglobulin concentrations or normal number of B cells –– 4A01.03 Transient hypogammaglobulinaemia of infancy –– 4A01.04 Immunodeficiencies with isotype or light chain deficiencies with normal number of B cells –– 4A01.05 Immunodeficiencies with severe reduction in serum IgG or IgA with normal or elevated IgM and normal numbers of B-cells –– 4A01.0Y Other specified immunodeficiencies with predominantly antibody defects –– 4A01.0Z Immunodeficiencies with predominantly antibody defects, unspecified –– 4A01.10 Severe combined immunodeficiencies –– 4A01.11 Major histocompatibility complex class I deficiency –– 4A01.12 Major histocompatibility complex class II deficiency –– 4A01.1Y Other specified combined immunodeficiencies –– 4A01.1Z Combined immunodeficiencies, unspecified –– 4A01.20 Immune dysregulation syndromes with hypopigmentation –– 4A01.21 Immune dysregulation syndromes presenting primarily with autoimmunity –– 4A01.22 Immune dysregulation syndromes presenting primarily with lymphoproliferation –– 4A01.23 Primary haemophagocytic lymphohistiocytosis –– 4A01.2Y Other specified diseases of immune dysregulation –– 4A01.2Z Diseases of immune dysregulation, unspecified –– 4A01.30 Immunodeficiency due to defects of the thymus –– 4A01.31 DNA repair defects other than combined T-cell or B-cell immunodeficiencies –– 4A01.32 Immuno-osseous dysplasia –– 4A01.33 Hepatic veno-occlusive disease - immunodeficiency syndrome –– 4A01.34 Hyperimmunoglobulin E syndromes 4A0Y Other specified primary immunodeficiencies 4A0Z Primary immunodeficiencies, unspecified 4A20 Acquired immunodeficiencies 4A20.0 Adult-onset immunodeficiency 4A20.1 Acquired immunodeficiency due to loss of immunoglobulin 4A20.Y Other specified acquired immunodeficiencies 4A20.Z Acquired immunodeficiencies, unspecified 4A40 Lupus erythematosus – 4A40.0 Systemic lupus erythematosus – 4A40.1 Drug-induced lupus erythematosus – 4A40.Y Other specified lupus erythematosus – 4A40.Z Lupus erythematosus, unspecified –– 4A40.00 Systemic lupus erythematosus with skin involvement –– 4A40.0Y Other specified systemic lupus erythematosus –– 4A40.0Z Systemic lupus erythematosus, unspecified 4A41 Idiopathic inflammatory myopathy – 4A41.0 Dermatomyositis – 4A41.1 Polymyositis – 4A41.2 Inclusion body myopathy – 4A41.Y Other specified idiopathic inflammatory myopathy – 4A41.Z Idiopathic inflammatory myopathy, unspecified –– 4A41.00 Adult dermatomyositis –– 4A41.01 Juvenile dermatomyositis –– 4A41.0Z Dermatomyositis, unspecified –– 4A41.10 Juvenile polymyositis –– 4A41.11 Paraneoplastic polymyositis –– 4A41.1Y Other specified polymyositis –– 4A41.1Z Polymyositis, unspecified –– 4A41.20 Inflammatory inclusion body myositis –– 4A41.21 Noninflammatory inclusion body myopathy –– 4A41.2Z Inclusion body myopathy, unspecified 4A42 Systemic sclerosis – 4A42.0 Paediatric onset systemic sclerosis – 4A42.1 Diffuse systemic sclerosis – 4A42.2 Limited systemic sclerosis – 4A42.Z Systemic sclerosis, unspecified 4A43 Overlap or undifferentiated nonorgan specific systemic autoimmune disease – 4A43.0 IgG4 related disease – 4A43.1 Mikulicz disease – 4A43.2 Sjögren syndrome – 4A43.3 Mixed connective tissue disease – 4A43.4 Diffuse eosinophilic fasciitis – 4A43.Y Other specified overlap non-organ specific systemic autoimmune disease – 4A43.Z Undifferentiated non-organ specific systemic autoimmune disease –– 4A43.20 Primary Sjögren syndrome –– 4A43.21 Secondary Sjögren syndrome –– 4A43.22 Paediatric onset Sjögren syndrome –– 4A43.2Y Other specified sjögren syndrome –– 4A43.2Z Sjögren syndrome, unspecified 4A44 Vasculitis – 4A44.0 Rhizomelic pseudopolyarthritis – 4A44.1 Aortic arch syndrome – 4A44.2 Giant cell arteritis – 4A44.3 Single organ vasculitis – 4A44.4 Polyarteritis nodosa – 4A44.5 Mucocutaneous lymph node syndrome – 4A44.6 Sneddon syndrome – 4A44.7 Primary angiitis of the central nervous system – 4A44.8 Thromboangiitis obliterans – 4A44.9 Immune complex small vessel vasculitis – 4A44.A Antineutrophil cytoplasmic antibody-associated vasculitis – 4A44.B Leukocytoclastic vasculitis – 4A44.Y Other specified vasculitis – 4A44.Z Vasculitis, unspecified –– 4A44.90 Cryoglobulinaemic vasculitis –– 4A44.91 Hypocomplementaemic urticarial vasculitis –– 4A44.92 IgA vasculitis –– 4A44.9Y Other specified immune complex small vessel vasculitis –– 4A44.9Z Immune complex small vessel vasculitis, unspecified –– 4A44.A0 Microscopic polyangiitis –– 4A44.A1 Granulomatosis with polyangiitis –– 4A44.A2 Eosinophilic granulomatosis with polyangiitis –– 4A44.AY Other specified antineutrophil cytoplasmic antibody-associated vasculitis –– 4A44.AZ Antineutrophil cytoplasmic antibody-associated vasculitis, unspecified –– 4A44.B0 Cutaneous leukocytoclastic vasculitis –– 4A44.BY Other specified leukocytoclastic vasculitis –– 4A44.BZ Leukocytoclastic vasculitis, unspecified 4A45 Antiphospholipid syndrome – 4A45.0 Primary antiphospholipid syndrome – 4A45.1 Secondary antiphospholipid syndrome – 4A45.2 Antiphospholipid syndrome in pregnancy – 4A45.3 Lupus anticoagulant-hypoprothrombinaemia syndrome – 4A45.Z Antiphospholipid syndrome, unspecified 4A4Y Other specified nonorgan specific systemic autoimmune disorders 4A4Z Nonorgan specific systemic autoimmune disorders, unspecified 4A60 Monogenic autoinflammatory syndromes – 4A60.0 Familial Mediterranean fever – 4A60.1 Cryopyrin-associated periodic syndromes – 4A60.2 Tumour necrosis factor receptor 1 associated periodic syndrome – 4A60.Y Other specified monogenic autoinflammatory syndromes – 4A60.Z Autoimflammatory syndrome, unspecified 4A61 SAPHO syndrome 4A62 Behçet disease 4A6Y Other specified autoinflammatory disorders 4A6Z Autoinflammatory disorders, unspecified 4A80 Allergic or hypersensitivity disorders involving the respiratory tract – 4A80.0 Drug-induced bronchospasm – 4A80.1 Bronchospasm provoked by allergy to food substance – 4A80.Y Other specified allergic or hypersensitivity disorders involving the respiratory tract – 4A80.Z Allergic or hypersensitivity disorders involving the respiratory tract, unspecified 4A81 Allergic or hypersensitivity disorders involving the eye 4A82 Allergic or hypersensitivity disorders involving skin or mucous membranes 4A83 Allergic or hypersensitivity disorders involving the gastrointestinal tract – 4A83.0 Food-induced eosinophilic gastroenteritis – 4A83.1 Food-induced eosinophilic oesophagitis – 4A83.Y Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract – 4A83.Z Allergic or hypersensitivity disorders involving the gastrointestinal tract, unspecified 4A84 Anaphylaxis – 4A84.0 Anaphylaxis due to allergic reaction to food – 4A84.1 Drug-induced anaphylaxis – 4A84.2 Anaphylaxis due to insect venom – 4A84.3 Anaphylaxis provoked by physical factors – 4A84.4 Anaphylaxis due to inhaled allergens – 4A84.5 Anaphylaxis due to contact with allergens – 4A84.6 Anaphylaxis secondary to mast cell disorder – 4A84.Y Other specified anaphylaxis – 4A84.Z Anaphylaxis, unspecified –– 4A84.30 Exercise-induced anaphylaxis –– 4A84.31 Cold-induced anaphylaxis –– 4A84.3Y Anaphylaxis provoked by other specified physical factors –– 4A84.3Z Anaphylaxis provoked by unspecified physical factors 4A85 Complex allergic or hypersensitivity conditions – 4A85.0 Drug or pharmacological agents hypersensitivity – 4A85.1 Hypersensitivity to herbal and alternative medical therapies – 4A85.2 Food hypersensitivity – 4A85.3 Allergic or hypersensitivity reactions to arthropods – 4A85.Y Other specified complex allergic or hypersensitivity conditions – 4A85.Z Complex allergic or hypersensitivity conditions, unspecified –– 4A85.00 Drug-induced liver hypersensitivity disease –– 4A85.01 Drug-induced kidney hypersensitivity –– 4A85.02 Drug-induced cytopenia –– 4A85.03 Drug-induced vasculitis –– 4A85.04 Multiple drug hypersensitivity syndrome –– 4A85.0Y Drug hypersensitivity of other specified type –– 4A85.0Z Drug hypersensitivity of unspecified type –– 4A85.20 Food-induced gastrointestinal hypersensitivity –– 4A85.21 Food-induced urticaria or angioedema –– 4A85.22 Allergic contact dermatitis due to food allergen –– 4A85.2Y Other specified food hypersensitivity –– 4A85.2Z Food hypersensitivity, unspecified –– 4A85.30 Systemic allergic reaction due to Hymenoptera venom –– 4A85.31 Cutaneous allergic or hypersensitivity reactions to Hymenoptera venom –– 4A85.32 Cutaneous allergic or hypersensitivity reactions to arthropods 4A8Y Allergic or hypersensitivity conditions of other specified type 4A8Z Allergic or hypersensitivity conditions of unspecified type 4B00 Disorders of neutrophil number – 4B00.0 Neutropaenia – 4B00.1 Neutrophilia – 4B00.Y Other specified disorders of neutrophil number –– 4B00.00 Constitutional neutropaenia –– 4B00.01 Acquired neutropaenia –– 4B00.0Z Neutropaenia, unspecified –– 4B00.10 Constitutional neutrophilia –– 4B00.11 Acquired neutrophilia –– 4B00.1Z Neutrophilia, unspecified 4B01 Disorders of neutrophil function – 4B01.0 Constitutional disorders of neutrophil function – 4B01.1 Acquired disorders of neutrophil function – 4B01.Z Disorders of neutrophil function, unspecified –– 4B01.00 Disorders of neutrophil adhesion –– 4B01.01 Disorders of neutrophil chemotaxis –– 4B01.02 Disorders of neutrophil granule formation or release –– 4B01.03 Disorders of neutrophil oxidative metabolism –– 4B01.0Y Other specified constitutional disorders of neutrophil function –– 4B01.0Z Constitutional disorders of neutrophil function, unspecified 4B02 Eosinopenia – 4B02.0 Constitutional decrease in eosinophil number – 4B02.1 Acquired decrease in eosinophil number – 4B02.Z Eosinopenia, unspecified 4B03 Eosinophilia – 4B03.0 Constitutional eosinophilia – 4B03.1 Acquired eosinophilia – 4B03.Z Eosinophilia, unspecified 4B04 Disorders with decreased monocyte counts 4B05 Disorders with increased monocyte counts 4B06 Acquired lymphopenia 4B07 Acquired lymphocytosis 4B0Y Other specified immune system disorders involving white cell lineages 4B0Z Immune system disorders involving white cell lineages, unspecified 4B20 Sarcoidosis – 4B20.0 Sarcoidosis of lung – 4B20.1 Sarcoidosis of lymph nodes – 4B20.2 Sarcoidosis of the digestive system – 4B20.3 Neurosarcoidosis – 4B20.4 Ocular sarcoidosis – 4B20.5 Cutaneous sarcoidosis – 4B20.Y Other specified sarcoidosis – 4B20.Z Sarcoidosis, unspecified 4B21 Polyclonal hypergammaglobulinaemia 4B22 Cryoglobulinaemia 4B23 Immune reconstitution inflammatory syndrome 4B24 Graft-versus-host disease – 4B24.0 Acute graft-versus-host disease – 4B24.1 Chronic graft-versus-host disease – 4B24.Y Other specified graft-versus-host disease – 4B24.Z Graft-versus-host disease, unspecified 4B2Y Other specified disorders involving the immune system 4B40 Diseases of thymus 4B40.0 Persistent hyperplasia of thymus 4B40.1 Abscess of thymus 4B40.2 Good syndrome 4B40.Y Other specified diseases of thymus 4B40.Z Diseases of thymus, unspecified 4B4Y Other specified diseases of the immune system 4B4Z Diseases of the immune system, unspecified 6B60 Dissociative neurological symptom disorder – 6B60.0 Dissociative neurological symptom disorder, with visual disturbance – 6B60.1 Dissociative neurological symptom disorder, with auditory disturbance – 6B60.2 Dissociative neurological symptom disorder, with vertigo or dizziness – 6B60.3 Dissociative neurological symptom disorder, with other sensory disturbance – 6B60.4 Dissociative neurological symptom disorder, with non-epileptic seizures – 6B60.5 Dissociative neurological symptom disorder, with speech disturbance – 6B60.6 Dissociative neurological symptom disorder, with paresis or weakness – 6B60.7 Dissociative neurological symptom disorder, with gait disturbance – 6B60.8 Dissociative neurological symptom disorder, with movement disturbance – 6B60.9 Dissociative neurological symptom disorder, with cognitive symptoms – 6B60.Y Dissociative neurological symptom disorder, with other specified symptoms – 6B60.Z Dissociative neurological symptom disorder, with unspecified symptoms –– 6B60.80 Dissociative neurological symptom disorder, with chorea –– 6B60.81 Dissociative neurological symptom disorder, with myoclonus –– 6B60.82 Dissociative neurological symptom disorder, with tremor –– 6B60.83 Dissociative neurological symptom disorder, with dystonia –– 6B60.84 Dissociative neurological symptom disorder, with facial spasm –– 6B60.85 Dissociative neurological symptom disorder, with Parkinsonism –– 6B60.8Y Dissociative neurological symptom disorder, with other specified movement disturbance –– 6B60.8Z Dissociative neurological symptom disorder, with unspecified movement disturbance 8A00 Parkinsonism – 8A00.0 Parkinson disease – 8A00.1 Atypical parkinsonism – 8A00.2 Secondary parkinsonism – 8A00.3 Functional parkinsonism – 8A00.Y Other specified parkinsonism – 8A00.Z Parkinsonism, unspecified –– 8A00.00 Sporadic Parkinson disease –– 8A00.01 Familial Parkinson disease –– 8A00.0Y Other specified Parkinson disease –– 8A00.0Z Parkinson disease, unspecified –– 8A00.10 Progressive supranuclear palsy –– 8A00.1Y Other specified atypical parkinsonism –– 8A00.1Z Atypical parkinsonism, unspecified –– 8A00.20 Parkinsonism due to heredodegenerative disorders –– 8A00.21 Hemiparkinsonism hemiatrophy syndrome –– 8A00.22 Infectious or postinfectious parkinsonism –– 8A00.23 Vascular parkinsonism –– 8A00.24 Drug-induced parkinsonism –– 8A00.25 Post traumatic Parkinsonism –– 8A00.26 Parkinsonism due to structural lesions –– 8A00.2Y Other specified secondary parkinsonism –– 8A00.2Z Secondary parkinsonism, unspecified 8A01 Choreiform disorders – 8A01.0 Benign hereditary chorea – 8A01.1 Secondary Chorea – 8A01.2 Hemichorea or hemiballismus – 8A01.Y Other specified choreiform disorders – 8A01.Z Choreiform disorders, unspecified –– 8A01.10 Huntington disease –– 8A01.11 Chorea due to Huntington disease-like conditions –– 8A01.12 Chorea due to Dentatorubral pallidoluysian atrophy –– 8A01.13 Chorea due to Wilson disease –– 8A01.14 Chorea due to infectious or para-infectious causes –– 8A01.15 Chorea due to systemic lupus erythematosus –– 8A01.16 Drug-induced chorea –– 8A01.1Y Other specified secondary chorea –– 8A01.1Z Secondary chorea, unspecified –– 8A01.20 Hemichorea –– 8A01.21 Ballism –– 8A01.22 Hemiballism –– 8A01.2Y Other specified hemichorea or hemiballismus –– 8A01.2Z Hemichorea or hemiballismus, unspecified 8A02 Dystonic disorders – 8A02.0 Primary dystonia – 8A02.1 Secondary dystonia – 8A02.2 Paroxysmal dystonia – 8A02.3 Functional dystonia or spasms – 8A02.Y Other specified dystonic disorders – 8A02.Z Dystonic disorders, unspecified –– 8A02.00 Benign essential blepharospasm –– 8A02.0Y Other specified primary dystonia –– 8A02.0Z Primary dystonia, unspecified –– 8A02.10 Drug-induced dystonia –– 8A02.11 Dystonia-plus –– 8A02.12 Dystonia associated with heredodegenerative disorders –– 8A02.1Y Other specified secondary dystonia –– 8A02.1Z Secondary dystonia, unspecified 8A03 Ataxic disorders – 8A03.0 Congenital ataxia – 8A03.1 Hereditary ataxia – 8A03.2 Non-hereditary degenerative ataxia – 8A03.3 Acquired ataxia – 8A03.Y Other specified ataxic disorders – 8A03.Z Ataxic disorders, unspecified –– 8A03.10 Friedreich ataxia –– 8A03.11 Ataxia due to Cerebrotendinous xanthomatosis –– 8A03.12 Ataxia due to Refsum disease –– 8A03.13 Ataxia due to abetalipoproteinemia –– 8A03.14 Hereditary episodic ataxia –– 8A03.15 Ataxia due to mitochondrial mutations –– 8A03.16 Spinocerebellar ataxia –– 8A03.1Y Other specified hereditary ataxia –– 8A03.1Z Hereditary ataxia, unspecified –– 8A03.20 Late onset cerebellar cortical atrophy –– 8A03.2Y Other specified non-hereditary degenerative ataxia –– 8A03.2Z Non-hereditary degenerative ataxia, unspecified –– 8A03.30 Ataxia due to alcoholic cerebellar degeneration –– 8A03.3Y Other specified acquired ataxia –– 8A03.3Z Acquired ataxia, unspecified 8A04 Disorders associated with tremor – 8A04.0 Enhanced physiological tremor – 8A04.1 Essential tremor or related tremors – 8A04.2 Rest tremor – 8A04.3 Secondary tremor – 8A04.4 Functional tremor – 8A04.Y Other specified disorders associated with tremor – 8A04.Z Disorders associated with tremor, unspecified –– 8A04.30 Tremor due to metabolic disorders –– 8A04.31 Tremor due to chronic or acute substance use –– 8A04.32 Tremor due to drug withdrawal –– 8A04.33 Tremor due to certain specified central nervous system diseases –– 8A04.3Y Other specified secondary tremor –– 8A04.3Z Secondary tremor, unspecified 8A05 Tic disorders – 8A05.0 Primary tics or tic disorders – 8A05.1 Secondary tics – 8A05.Y Other specified tic disorders – 8A05.Z Tic disorders, unspecified –– 8A05.00 Tourette syndrome –– 8A05.01 Chronic motor tic disorder –– 8A05.02 Chronic phonic tic disorder –– 8A05.03 Transient motor tics –– 8A05.0Y Other specified primary tics or tic disorders –– 8A05.0Z Primary tics or tic disorders, unspecified –– 8A05.10 Infectious or postinfectious tics –– 8A05.11 Tics associated with developmental disorders –– 8A05.1Y Other specified secondary tics –– 8A05.1Z Secondary tics, unspecified 8A06 Myoclonic disorders – 8A06.0 Essential myoclonus – 8A06.1 Segmental myoclonus – 8A06.2 Focal myoclonus – 8A06.Y Other specified myoclonic disorders – 8A06.Z Myoclonic disorders, unspecified –– 8A06.20 Palatal myoclonus –– 8A06.21 Chronic hiccups –– 8A06.2Y Other specified focal myoclonus –– 8A06.2Z Focal myoclonus, unspecified 8A07 Certain specified movement disorder – 8A07.0 Stereotypies – 8A07.1 Akathisia – 8A07.2 Excessive startle reflex –– 8A07.00 Primary stereotypy –– 8A07.01 Secondary stereotypy –– 8A07.0Y Other specified stereotypies –– 8A07.0Z Stereotypies, unspecified 8A0Y Other specified movement disorders 8A0Z Movement disorders, unspecified 8A20 Alzheimer disease 8A21 Progressive focal atrophies – 8A21.0 Posterior cortical atrophy – 8A21.Y Other specified progressive focal atrophies – 8A21.Z Progressive focal atrophies, unspecified 8A22 Lewy body disease 8A23 Frontotemporal lobar degeneration 8A2Y Other specified disorders with neurocognitive impairment as a major feature 8A2Z Disorders with neurocognitive impairment as a major feature, unspecified 8A40 Multiple sclerosis – 8A40.0 Relapsing-remitting multiple sclerosis – 8A40.1 Primary progressive multiple sclerosis – 8A40.2 Secondary progressive multiple sclerosis – 8A40.Y Other specified multiple sclerosis – 8A40.Z Multiple sclerosis, unspecified 8A41 Isolated demyelinating syndromes of the central nervous system – 8A41.0 Transverse myelitis – 8A41.1 Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive – 8A41.Y Other specified isolated demyelinating syndromes of the central nervous system – 8A41.Z Isolated demyelinating syndromes of the central nervous system, unspecified 8A42 Acute disseminated encephalomyelitis – 8A42.0 Acute haemorrhagic leukoencephalitis – 8A42.Y Other specified acute disseminated encephalomyelitis – 8A42.Z Acute disseminated encephalomyelitis, unspecified 8A43 Neuromyelitis optica – 8A43.0 Neuromyelitis optica aquaporin-4 antibody positive – 8A43.1 Neuromyelitis optica aquaporin-4 antibody negative – 8A43.2 Single transverse myelitis aquaporin-4 antibody positive – 8A43.3 Recurrent transverse myelitis aquaporin-4 antibody positive – 8A43.4 Single optic neuritis aquaporin-4 antibody positive – 8A43.5 Recurrent optic neuritis aquaporin-4 antibody positive – 8A43.Y Other specified neuromyelitis optica – 8A43.Z Neuromyelitis optica, unspecified 8A44 Leukodystrophies – 8A44.0 Pelizaeus-Merzbacher disease – 8A44.1 Adrenoleukodystrophy – 8A44.2 Alexander disease – 8A44.3 Certain specified leukodystrophies – 8A44.4 Krabbe disease – 8A44.Z Leukodystrophies, unspecified 8A45 Secondary white matter disorders – 8A45.0 White matter disorders due to infections – 8A45.1 White matter disorders due to toxicity – 8A45.2 White matter disorders due to vascular abnormality or ischemia – 8A45.3 White matter disorders due to nutritional deficiency – 8A45.4 White matter disorders due to certain specified systemic disease – 8A45.Y Other specified secondary white matter disorders – 8A45.Z Secondary white matter disorders, unspecified –– 8A45.00 Human T-cell lymphotropic virus-associated myelopathy –– 8A45.01 Subacute sclerosing panencephalitis –– 8A45.02 Progressive multifocal leukoencephalopathy –– 8A45.0Y Other specified white matter disorders due to infections –– 8A45.0Z White matter disorders due to infections, unspecified –– 8A45.20 White matter disorder due to CADASIL –– 8A45.21 Subacute necrotising myelitis –– 8A45.2Y Other specified white matter disorders due to vascular abnormality or ischemia –– 8A45.2Z White matter disorders due to vascular abnormality or ischemia, unspecified –– 8A45.30 White matter disorder due to vitamin B12 deficiency –– 8A45.31 Central pontine myelinolysis –– 8A45.3Y Other specified white matter disorders due to nutritional deficiency –– 8A45.3Z White matter disorders due to nutritional deficiency, unspecified –– 8A45.40 Demyelination due to sarcoidosis –– 8A45.41 Demyelination due to systemic lupus erythematosus –– 8A45.42 Demyelination due to Sjögren disease –– 8A45.43 Demyelination due to Behcet disease –– 8A45.44 Demyelination due to systemic vasculitis –– 8A45.45 Demyelination due to mitochondrial disease –– 8A45.4Z White matter disorders due to certain specified systemic disease, unspecified 8A46 Central demyelination of corpus callosum 8A4Y Other specified multiple sclerosis or other white matter disorders 8A4Z Multiple sclerosis or other white matter disorders, unspecified 8A60 Epilepsy due to structural or metabolic conditions or diseases – 8A60.0 Epilepsy due to prenatal or perinatal brain insults – 8A60.1 Epilepsy due to cerebrovascular disorders – 8A60.2 Epilepsy due to degenerative brain disorders – 8A60.3 Epilepsy due to dementias – 8A60.4 Epilepsy due to central nervous system infections or infestations – 8A60.5 Epilepsy due to injuries to the head – 8A60.6 Epilepsy due to tumours of the nervous system – 8A60.7 Epilepsy with mesial temporal sclerosis – 8A60.8 Epilepsy due to immune disorders – 8A60.9 Epilepsy due to abnormalities of brain development – 8A60.A Epilepsy due to genetic syndromes with widespread or progressive effects – 8A60.B Epilepsy due to multiple sclerosis or other demyelinating disorders – 8A60.Y Epilepsy due to other structural or metabolic condition or disease – 8A60.Z Epilepsy due to unspecified structural or metabolic condition or disease –– 8A60.00 Epilepsy due to prenatal or perinatal vascular insults –– 8A60.01 Epilepsy due to neonatal hypoxic ischemic encephalopathy –– 8A60.0Y Epilepsy due to other prenatal or perinatal brain insults –– 8A60.0Z Epilepsy due to unspecified prenatal or perinatal brain insults 8A61 Genetic or presumed genetic syndromes primarily expressed as epilepsy – 8A61.0 Genetic epileptic syndromes with neonatal onset – 8A61.1 Genetic epileptic syndromes with onset in infancy – 8A61.2 Genetic epileptic syndromes with childhood onset – 8A61.3 Genetic epileptic syndrome with adolescent or adult onset – 8A61.4 Genetic epileptic syndromes with variable age of onset – 8A61.Y Other specified genetic or presumed genetic syndromes primarily expressed as epilepsy – 8A61.Z Genetic or presumed genetic syndromes primarily expressed as epilepsy, unspecified –– 8A61.00 Pyridoxal dependent epilepsy –– 8A61.0Y Other specified genetic epileptic syndromes with neonatal onset –– 8A61.0Z Genetic epileptic syndromes with neonatal onset, unspecified –– 8A61.10 Benign familial infantile epilepsy –– 8A61.11 Dravet syndrome –– 8A61.12 Epilepsy of infancy with migrating focal seizures –– 8A61.1Y Other specified genetic epileptic syndromes with onset in infancy –– 8A61.1Z Genetic epileptic syndromes with onset in infancy, unspecified –– 8A61.20 Benign childhood epilepsy with centro-temporal spikes –– 8A61.21 Childhood absence epilepsy –– 8A61.22 Epilepsy with myoclonic-astatic seizures –– 8A61.23 Myoclonic absences or absences with myoclonias –– 8A61.2Y Other specified genetic epileptic syndromes with childhood onset –– 8A61.2Z Genetic epileptic syndromes with childhood onset, unspecified –– 8A61.30 Juvenile myoclonic epilepsy –– 8A61.31 Juvenile absence epilepsy –– 8A61.32 Benign adult familial myoclonus epilepsy –– 8A61.3Y Other specified genetic epileptic syndrome with adolescent or adult onset –– 8A61.3Z Genetic epileptic syndrome with adolescent or adult onset, unspecified –– 8A61.40 Reflex epilepsies –– 8A61.41 Progressive myoclonic epilepsy –– 8A61.4Y Other specified genetic epileptic syndromes with variable age of onset –– 8A61.4Z Genetic epileptic syndromes with variable age of onset, unspecified 8A62 Epileptic encephalopathies – 8A62.0 Infantile spasms – 8A62.1 Lennox-Gastaut syndrome – 8A62.2 Acquired epileptic aphasia – 8A62.Y Other specified epileptic encephalopathies – 8A62.Z Epileptic encephalopathies, unspecified 8A63 Seizure due to acute causes – 8A63.0 Febrile seizures – 8A63.Y Seizure due to other acute cause – 8A63.Z Seizure due to unspecified acute cause –– 8A63.00 Simple febrile seizures –– 8A63.01 Complex febrile seizures –– 8A63.0Y Other specified febrile seizures –– 8A63.0Z Febrile seizures, unspecified 8A64 Single seizure due to remote causes 8A65 Single unprovoked seizure 8A66 Status epilepticus – 8A66.0 Convulsive status epilepticus – 8A66.1 Non-convulsive status epilepticus – 8A66.Y Other specified status epilepticus – 8A66.Z Status epilepticus, unspecified –– 8A66.10 Absence status epilepticus –– 8A66.1Y Other specified non-convulsive status epilepticus –– 8A66.1Z Non-convulsive status epilepticus, unspecified 8A67 Acute repetitive seizures 8A68 Types of seizures – 8A68.0 Focal unaware seizure – 8A68.1 Absence seizures, atypical – 8A68.2 Absence seizures, typical – 8A68.3 Focal aware seizure – 8A68.4 Generalised tonic-clonic seizure – 8A68.5 Generalised myoclonic seizure – 8A68.6 Generalised tonic seizure – 8A68.7 Generalised atonic seizure – 8A68.Y Other specified type of seizure – 8A68.Z Type of seizure, unspecified 8A6Y Other specified epilepsy or seizures 8A6Z Epilepsy or seizures, unspecified 8A80 Migraine – 8A80.0 Migraine without aura – 8A80.1 Migraine with aura – 8A80.2 Chronic migraine – 8A80.3 Complications related to migraine – 8A80.4 Cyclic vomiting syndrome – 8A80.Y Other specified migraine – 8A80.Z Migraine, unspecified –– 8A80.10 Hemiplegic migraine –– 8A80.1Y Other specified migraine with aura –– 8A80.1Z Migraine with aura, unspecified –– 8A80.30 Status migrainosus –– 8A80.3Y Other specified complications related to migraine 8A81 Tension-type headache – 8A81.0 Infrequent episodic tension-type headache – 8A81.1 Frequent episodic tension-type headache – 8A81.2 Chronic tension-type headache – 8A81.Y Other specified tension-type headache – 8A81.Z Tension-type headache, unspecified 8A82 Trigeminal autonomic cephalalgias 8A83 Other primary headache disorder 8A84 Secondary headache – 8A84.0 Acute headache associated with traumatic injury to the head – 8A84.1 Persistent headache associated with traumatic injury to the head – 8A84.Y Other specified secondary headache – 8A84.Z Secondary headache, unspecified 8A85 Painful cranial neuropathies or other facial pains 8A8Y Other specified headache disorders 8A8Z Headache disorders, unspecified – 8B00 Intracerebral haemorrhage –– 8B00.0 Deep hemispheric haemorrhage –– 8B00.1 Lobar haemorrhage –– 8B00.2 Brainstem haemorrhage –– 8B00.3 Cerebellar haemorrhage –– 8B00.4 Intraventricular haemorrhage without parenchymal haemorrhage –– 8B00.5 Haemorrhage of multiple sites –– 8B00.Z Intracerebral haemorrhage, site unspecified – 8B01 Subarachnoid haemorrhage –– 8B01.0 Aneurysmal subarachnoid haemorrhage –– 8B01.1 Non-aneurysmal subarachnoid haemorrhage –– 8B01.2 Subarachnoid haemorrhage not known if aneurysmal or non-aneurysmal – 8B02 Nontraumatic subdural haemorrhage – 8B03 Nontraumatic epidural haemorrhage – 8B0Z Intracranial haemorrhage, unspecified – 8B10 Transient ischaemic attack –– 8B10.0 Amaurosis fugax –– 8B10.Y Other specified transient ischaemic attack –– 8B10.Z Transient ischaemic attack, unspecified – 8B11 Cerebral ischaemic stroke –– 8B11.0 Cerebral ischaemic stroke due to extracranial large artery atherosclerosis –– 8B11.1 Cerebral ischaemic stroke due to intracranial large artery atherosclerosis –– 8B11.2 Cerebral ischaemic stroke due to embolic occlusion –– 8B11.3 Cerebral ischaemic stroke due to small artery occlusion –– 8B11.4 Cerebral ischaemic stroke due to other known cause –– 8B11.5 Cerebral ischaemic stroke of unknown cause ––– 8B11.20 Cerebral ischaemic stroke due to cardiac embolism ––– 8B11.21 Cerebral ischaemic stroke due to aortic arch embolism ––– 8B11.22 Cerebral ischaemic stroke due to paradoxical embolism ––– 8B11.2Y Cerebral ischaemic stroke due to other specified embolic occlusion ––– 8B11.2Z Cerebral ischaemic stroke due to embolic occlusion, unspecified ––– 8B11.40 Cerebral ischaemic stroke due to global hypoperfusion with watershed infarct ––– 8B11.41 Cerebral ischaemic stroke due to other non-atherosclerotic arteriopathy ––– 8B11.42 Cerebral ischaemic stroke due to hypercoagulable state ––– 8B11.43 Cerebral ischaemic stroke in association with subarachnoid haemorrhage ––– 8B11.44 Cerebral ischemic stroke from dissection ––– 8B11.50 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of extracranial large artery ––– 8B11.51 Cerebral ischaemic stroke due to unspecified occlusion or stenosis of intracranial large artery ––– 8B11.5Z Cerebral ischaemic stroke, unspecified – 8B1Y Other specified cerebral ischaemia – 8B1Z Cerebral ischaemia, unspecified 8B20 Stroke not known if ischaemic or haemorrhagic 8B21 Cerebrovascular disease with no acute cerebral symptom – 8B21.0 Silent cerebral infarct – 8B21.1 Silent cerebral microbleed – 8B21.Y Other specified cerebrovascular disease with no acute cerebral symptom – 8B21.Z Cerebrovascular disease with no acute cerebral symptom, unspecified 8B22 Certain specified cerebrovascular diseases – 8B22.0 Dissection of cerebral arteries – 8B22.1 Cerebral venous thrombosis – 8B22.2 Cerebral vasoconstriction syndromes – 8B22.3 Isolated cerebral amyloid angiopathy – 8B22.4 Intracranial vascular malformation – 8B22.5 Cerebral aneurysm, nonruptured – 8B22.6 Familial cerebral saccular aneurysm – 8B22.7 Cerebral arteritis, not elsewhere classified – 8B22.8 Hypertensive encephalopathy – 8B22.9 Migraine-induced stroke – 8B22.A Subclavian steal syndrome – 8B22.B Moyamoya syndrome – 8B22.C Hereditary cerebrovascular diseases – 8B22.Y Other specified cerebrovascular disease –– 8B22.40 Arteriovenous malformation of cerebral vessels –– 8B22.41 Cerebral cavernous malformation –– 8B22.42 Dural arteriovenous fistula –– 8B22.43 Carotid cavernous fistula –– 8B22.4Y Other specified intracranial vascular malformation –– 8B22.4Z Intracranial vascular malformation, unspecified –– 8B22.70 Primary cerebral arteritis –– 8B22.7Y Other specified cerebral arteritis, not elsewhere classified –– 8B22.7Z Cerebral arteritis, not elsewhere classified, unspecified –– 8B22.C0 CADASIL - [cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.C1 CARASIL - [cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy] syndrome –– 8B22.CY Other specified hereditary cerebrovascular diseases –– 8B22.CZ Hereditary cerebrovascular diseases, unspecified 8B23 Cerebrovascular abnormalities 8B24 Hypoxic-ischaemic encephalopathy – 8B24.0 Anoxic-ischaemic encephalopathy – 8B24.Y Other specified hypoxic-ischaemic encephalopathy – 8B24.Z Hypoxic-ischaemic encephalopathy, unspecified 8B25 Late effects of cerebrovascular disease – 8B25.0 Late effects of cerebral ischemic stroke – 8B25.1 Late effects of intracerebral haemorrhage – 8B25.2 Late effects of subarachnoid haemorrhage – 8B25.3 Late effects of other nontraumatic intracranial haemorrhage – 8B25.4 Late effects of stroke not known if ischaemic or haemorrhagic – 8B25.Y Late effects of other specified cerebrovascular disease – 8B25.Z Late effects of cerebrovascular disease, unspecified 8B26 Vascular syndromes of brain in cerebrovascular diseases – 8B26.0 Brainstem stroke syndrome – 8B26.1 Cerebellar stroke syndrome – 8B26.2 Middle cerebral artery syndrome – 8B26.3 Anterior cerebral artery syndrome – 8B26.4 Posterior cerebral artery syndrome – 8B26.5 Lacunar syndromes – 8B26.Y Other specified vascular syndromes of brain in cerebrovascular diseases – 8B26.Z Vascular syndromes of brain in cerebrovascular diseases, unspecified –– 8B26.50 Pure motor lacunar syndrome –– 8B26.51 Pure sensory lacunar syndrome –– 8B26.5Y Other specified lacunar syndromes –– 8B26.5Z Lacunar syndromes, unspecified 8B2Z Cerebrovascular diseases, unspecified 8B40 Cauda equina syndrome 8B41 Myelitis 8B42 Myelopathy 8B43 Non-compressive vascular myelopathies – 8B43.0 Acute arterial infarction of the spinal cord – 8B43.1 Acute venous infarction of the spinal cord – 8B43.2 Chronic venous infarction of the spinal cord – 8B43.Y Other specified non-compressive vascular myelopathies – 8B43.Z Non-compressive vascular myelopathies, unspecified 8B44 Degenerative myelopathic disorders – 8B44.0 Hereditary spastic paraplegia – 8B44.Y Other specified degenerative myelopathic disorders – 8B44.Z Degenerative myelopathic disorders, unspecified –– 8B44.00 Autosomal dominant hereditary spastic paraplegia –– 8B44.01 Autosomal recessive hereditary spastic paraplegia –– 8B44.02 X-linked hereditary spastic paraplegia –– 8B44.0Y Other specified hereditary spastic paraplegia –– 8B44.0Z Hereditary spastic paraplegia, unspecified 8B4Y Other specified spinal cord disorders excluding trauma 8B4Z Spinal cord disorders excluding trauma, unspecified 8B60 Motor neuron disease – 8B60.0 Amyotrophic lateral sclerosis – 8B60.1 Progressive bulbar palsy – 8B60.2 Progressive pseudobulbar palsy – 8B60.3 Progressive muscular atrophy – 8B60.4 Primary lateral sclerosis – 8B60.5 Amyotrophic lateral sclerosis-Plus – 8B60.6 Monomelic amyotrophy – 8B60.7 Madras type motor neuron disease – 8B60.Y Other specified motor neuron disease – 8B60.Z Motor neuron disease, unspecified 8B61 Spinal muscular atrophy – 8B61.0 Infantile spinal muscular atrophy, Type I – 8B61.1 Late infantile spinal muscular atrophy, Type II – 8B61.2 Juvenile form spinal muscular dystrophy, Type III – 8B61.3 Adult onset spinal muscular atrophy, Type IV – 8B61.4 Localised spinal muscular atrophy – 8B61.Y Other specified spinal muscular atrophy – 8B61.Z Spinal muscular atrophy, unspecified 8B62 Post polio progressive muscular atrophy 8B6Y Other specified motor neuron diseases or related disorders 8B6Z Motor neuron diseases or related disorders, unspecified – 8B80 Disorders of olfactory nerve – 8B81 Disorders of vestibulocochlear nerve –– 8B81.0 Brainstem lesion –– 8B81.Y Other specified disorders of vestibulocochlear nerve –– 8B81.Z Disorders of vestibulocochlear nerve, unspecified – 8B82 Disorders of trigeminal nerve –– 8B82.0 Trigeminal neuralgia –– 8B82.Z Disorders of trigeminal nerve, unspecified – 8B83 Disorders of spinal accessory nerve – 8B84 Disorders of hypoglossal nerve – 8B85 Disorders of multiple cranial nerves – 8B86 Disorders of vagus nerve – 8B87 Disorders of glossopharyngeal nerve – 8B88 Disorders of facial nerve –– 8B88.0 Bell palsy –– 8B88.1 Facial myokymia –– 8B88.2 Hemifacial spasm –– 8B88.3 Facial neuritis –– 8B88.Y Other specified disorders of facial nerve –– 8B88.Z Disorders of facial nerve, unspecified – 8B8Y Other specified disorders of cranial nerves – 8B8Z Disorders of cranial nerves, unspecified – 8B90 Nerve root and plexus compressions – 8B91 Brachial plexus disorders –– 8B91.0 Neuralgic shoulder amyotrophy –– 8B91.1 Thoracic outlet syndrome due to cervical rib –– 8B91.Y Other specified brachial plexus disorders –– 8B91.Z Brachial plexus disorders, unspecified – 8B92 Lumbosacral plexus disorders –– 8B92.0 Post radiation lumbosacral plexopathy –– 8B92.1 Vasculitic lumbosacral plexopathy –– 8B92.2 Diabetic lumbosacral plexopathy –– 8B92.3 Lumbosacral radiculoplexopathy –– 8B92.Y Other specified lumbosacral plexus disorders –– 8B92.Z Lumbosacral plexus disorders, unspecified – 8B93 Radiculopathy –– 8B93.0 Radiculopathy due to compression –– 8B93.1 Radiculopathy due to metabolic disorders –– 8B93.2 Radiculopathy due to electric shock or lightning –– 8B93.3 Radiculopathy due to radiation injury –– 8B93.4 Radiculopathy due to nutritional deficiencies –– 8B93.5 Radiculopathy due to toxicity –– 8B93.6 Radiculopathy due to intervertebral disc disorders –– 8B93.7 Radiculopathy due to neoplastic disease –– 8B93.8 Radiculopathy due to spondylosis –– 8B93.Y Other specified radiculopathy –– 8B93.Z Radiculopathy, unspecified – 8B94 Diabetic radiculoplexoneuropathy – 8B95 Secondary brachial plexus lesion due to certain specified disorders – 8B9Y Other specified nerve root or plexus disorders – 8B9Z Nerve root or plexus disorders, unspecified – 8C00 Idiopathic progressive neuropathy – 8C01 Inflammatory polyneuropathy –– 8C01.0 Acute inflammatory demyelinating polyneuropathy –– 8C01.1 Post vaccinal neuropathy –– 8C01.2 Subacute inflammatory demyelinating polyneuropathy –– 8C01.3 Chronic inflammatory demyelinating polyneuropathy –– 8C01.Y Other specified inflammatory polyneuropathy –– 8C01.Z Inflammatory polyneuropathy, unspecified – 8C03 Other secondary polyneuropathy –– 8C03.0 Diabetic polyneuropathy –– 8C03.1 Polyneuropathy due to infectious diseases –– 8C03.2 Polyneuropathy in neoplastic disease –– 8C03.3 Polyneuropathy in nutritional deficiency –– 8C03.4 Polyneuropathy in systemic connective tissue disorders –– 8C03.Y Other specified secondary polyneuropathy –– 8C03.Z Other secondary polyneuropathy, unspecified – 8C0Y Other specified polyneuropathy – 8C0Z Polyneuropathy, unspecified – 8C10 Mononeuropathies of upper limb –– 8C10.0 Carpal tunnel syndrome –– 8C10.1 Lesion of ulnar nerve –– 8C10.2 Lesion of radial nerve –– 8C10.Y Other specified mononeuropathies of upper limb –– 8C10.Z Mononeuropathies of upper limb, unspecified – 8C11 Mononeuropathies of lower limb –– 8C11.0 Lesion of sciatic nerve –– 8C11.1 Meralgia paraesthetica –– 8C11.2 Lesion of femoral nerve –– 8C11.3 Lesion of common peroneal nerve –– 8C11.4 Lesion of tibial nerve –– 8C11.5 Tarsal tunnel syndrome –– 8C11.6 Lesion of plantar nerve –– 8C11.Y Other specified mononeuropathies of lower limb –– 8C11.Z Mononeuropathies of lower limb, unspecified ––– 8C11.00 Sciatic nerve piriformis syndrome ––– 8C11.0Y Other specified lesion of sciatic nerve ––– 8C11.0Z Lesion of sciatic nerve, unspecified – 8C12 Certain specified mononeuropathies –– 8C12.0 Intercostal neuropathy –– 8C12.1 Mononeuritis multiplex –– 8C12.2 Lesion of suprascapular nerve –– 8C12.3 Lesion of axillary nerve –– 8C12.4 Lesion of long thoracic nerve –– 8C12.5 Traumatic neuroma, not otherwise specified –– 8C12.Y Mononeuropathy of other specified nerve – 8C1Y Mononeuropathy of other specified site – 8C1Z Mononeuropathy of unspecified site – 8C20 Hereditary motor and sensory neuropathy –– 8C20.0 Charcot-Marie-Tooth disease 1 demyelinating –– 8C20.1 Charcot-Marie-Tooth disease 2 axonal –– 8C20.2 Intermediate Charcot-Marie-Tooth disease –– 8C20.Y Other specified hereditary motor and sensory neuropathy –– 8C20.Z Hereditary motor and sensory neuropathy, unspecified – 8C21 Hereditary sensory or autonomic neuropathy –– 8C21.0 Hereditary sensory and autonomic neuropathy type I –– 8C21.1 Hereditary sensory and autonomic neuropathy type III –– 8C21.2 Hereditary sensory and autonomic neuropathy type IV –– 8C21.3 Hereditary sensory and autonomic neuropathy type V –– 8C21.Y Other specified hereditary sensory or autonomic neuropathy –– 8C21.Z Hereditary sensory or autonomic neuropathy, unspecified – 8C2Y Other specified hereditary neuropathy – 8C2Z Hereditary neuropathy, unspecified 8C4Y Other specified disorders of nerve root, plexus or peripheral nerves 8C4Z Disorders of nerve root, plexus or peripheral nerves, unspecified – 8C60 Myasthenia gravis –– 8C60.0 Drug-induced myasthenia gravis –– 8C60.Y Other specified myasthenia gravis –– 8C60.Z Myasthenia gravis, unspecified – 8C61 Congenital myasthenic syndromes – 8C62 Lambert-Eaton syndrome – 8C6Y Other specified myasthenia gravis and neuromuscular junction disorders – 8C6Z Unspecified myasthenia gravis or neuromuscular junction disorders – 8C70 Muscular dystrophy –– 8C70.0 Becker muscular dystrophy –– 8C70.1 Duchenne muscular dystrophy –– 8C70.2 Emery-Dreifuss muscular dystrophy –– 8C70.3 Facioscapulohumeral muscular dystrophy –– 8C70.4 Limb-girdle muscular dystrophy –– 8C70.5 Scapuloperoneal muscular dystrophy –– 8C70.6 Congenital muscular dystrophy –– 8C70.Y Other specified muscular dystrophy –– 8C70.Z Muscular dystrophy, unspecified ––– 8C70.40 Dominant limb-girdle muscular dystrophy ––– 8C70.41 Recessive limb-girdle muscular dystrophy ––– 8C70.4Y Other specified limb-girdle muscular dystrophy ––– 8C70.4Z Limb-girdle muscular dystrophy, unspecified – 8C71 Myotonic disorders –– 8C71.0 Myotonic dystrophy –– 8C71.1 Chondrodystrophic myotonia –– 8C71.2 Myotonia congenita –– 8C71.3 Drug-induced myotonia –– 8C71.4 Neuromyotonia –– 8C71.5 Pseudomyotonia –– 8C71.Y Other specified myotonic disorders –– 8C71.Z Myotonic disorders, unspecified – 8C72 Congenital myopathies –– 8C72.0 Congenital myopathy with structural abnormalities –– 8C72.1 Congenital myopathy with no structural abnormalities –– 8C72.Y Other specified congenital myopathies –– 8C72.Z Congenital myopathies, unspecified ––– 8C72.00 Nemaline myopathy ––– 8C72.01 Centronuclear myopathy ––– 8C72.02 Central core disease ––– 8C72.0Y Other specified congenital myopathy with structural abnormalities ––– 8C72.0Z Congenital myopathy with structural abnormalities, unspecified – 8C73 Mitochondrial myopathies –– 8C73.0 Autosomal recessive cardiomyopathy or ophthalmoplegia –– 8C73.1 Neuropathy, ataxia, and retinitis pigmentosa –– 8C73.Y Other specified mitochondrial myopathies –– 8C73.Z Mitochondrial myopathies, unspecified – 8C74 Periodic paralyses or disorders of muscle membrane excitability –– 8C74.0 Paramyotonia congenita –– 8C74.1 Periodic paralysis –– 8C74.Y Other specified periodic paralyses or disorders of muscle membrane excitability –– 8C74.Z Periodic paralyses or disorders of muscle membrane excitability, unspecified ––– 8C74.10 Hypokalaemic periodic paralysis ––– 8C74.11 Hyperkalaemic periodic paralysis ––– 8C74.1Y Other specified periodic paralysis ––– 8C74.1Z Periodic paralysis, unspecified – 8C75 Distal myopathies – 8C76 Myofibrillar myopathy – 8C77 Ocular myopathy – 8C78 Malignant hyperthermia or hyperpyrexia – 8C7Y Other specified primary disorders of muscles – 8C7Z Primary disorders of muscles, unspecified – 8C80 Drug-induced myopathy – 8C81 Autoimmune myopathy – 8C82 Myopathy in certain specified infectious or parasitic disease – 8C83 Myopathy in certain specified endocrine disease – 8C84 Secondary rhabdomyolysis – 8C8Y Other specified secondary myopathies – 8C8Z Secondary myopathies, unspecified 8D0Y Other specified diseases of neuromuscular junction or muscle 8D0Z Diseases of neuromuscular junction or muscle, unspecified 8D20 Spastic cerebral palsy – 8D20.0 Spastic unilateral cerebral palsy – 8D20.1 Spastic bilateral cerebral palsy – 8D20.Y Other specified spastic cerebral palsy – 8D20.Z Spastic cerebral palsy, unspecified –– 8D20.10 Spastic quadriplegic cerebral palsy –– 8D20.11 Spastic diplegic cerebral palsy –– 8D20.1Z Spastic bilateral cerebral palsy, unspecified 8D21 Dyskinetic cerebral palsy 8D22 Ataxic cerebral palsy 8D23 Worster-Drought syndrome 8D2Y Other specified cerebral palsy 8D2Z Cerebral palsy, unspecified 8D40 Neurological disorders due to nutrient deficiency – 8D40.0 Encephalopathy due to nutritional deficiency – 8D40.1 Neuropathy due to nutritional deficiency – 8D40.2 Myopathy due to nutritional deficiency – 8D40.3 Intellectual developmental disorder due to nutritional deficiency – 8D40.Y Other specified neurological disorders due to nutrient deficiency – 8D40.Z Neurological disorders due to nutrient deficiency, unspecified 8D41 Neurological disorders due to an excess of micro or macro nutrients – 8D41.0 Peripheral neuropathy due to vitamin B6 hyperalimentation – 8D41.1 Myopathy due to hypercalcaemia – 8D41.2 Pseudotumour Cerebri related to Hypervitaminosis A – 8D41.Y Other specified neurological disorders due to an excess of micro or macro nutrients – 8D41.Z Neurological disorders due to an excess of micro or macro nutrients, unspecified 8D42 Neurological disorders due to overweight or obesity in adults or children 8D43 Neurological disorders due to toxicity – 8D43.0 Encephalopathy due to toxicity – 8D43.1 Cognitive impairment due to toxicity – 8D43.2 Neuropathy due to toxicity – 8D43.3 Myopathy due to toxicity – 8D43.4 Movement disorders due to toxicity – 8D43.5 Cassava poisoning – 8D43.Y Other specified neurological disorders due to toxicity – 8D43.Z Neurological disorders due to toxicity, unspecified –– 8D43.00 Encephalopathy due to ammonia –– 8D43.0Y Other specified encephalopathy due to toxicity –– 8D43.0Z Encephalopathy due to toxicity, unspecified –– 8D43.20 Drug-induced polyneuropathy –– 8D43.21 Post radiation polyneuropathy –– 8D43.2Y Other specified neuropathy due to toxicity –– 8D43.2Z Neuropathy due to toxicity, unspecified 8D44 Alcohol-related neurological disorders – 8D44.0 Alcoholic polyneuropathy – 8D44.1 Alcoholic myopathy – 8D44.Y Other specified alcohol-related neurological disorders – 8D44.Z Alcohol-related neurological disorders, unspecified 8D4Y Other specified nutritional or toxic disorders of the nervous system 8D4Z Nutritional or toxic disorders of the nervous system, unspecified 8D60 Increased intracranial pressure – 8D60.0 Brain herniation syndromes – 8D60.1 Cerebral oedema – 8D60.Y Other specified increased intracranial pressure – 8D60.Z Increased intracranial pressure, unspecified 8D61 Intracranial hypotension – 8D61.0 Spontaneous intracranial hypotension – 8D61.1 Secondary intracranial hypotension – 8D61.Y Other specified intracranial hypotension – 8D61.Z Intracranial hypotension, unspecified 8D62 Cerebrospinal fluid rhinorrhoea 8D63 Cerebrospinal fluid otorrhoea 8D64 Hydrocephalus – 8D64.0 Communicating hydrocephalus – 8D64.1 Non-communicating hydrocephalus – 8D64.2 Ex-vacuo hydrocephalus – 8D64.Z Hydrocephalus, unspecified –– 8D64.00 Increased cerebrospinal fluid production –– 8D64.01 Congenital agenesis of arachnoid villi –– 8D64.02 Post haemorrhagic hydrocephalus –– 8D64.03 Post traumatic hydrocephalus –– 8D64.04 Normal-pressure hydrocephalus –– 8D64.0Y Other specified communicating hydrocephalus –– 8D64.0Z Communicating hydrocephalus, unspecified –– 8D64.10 Hydrocephalus due to structural malformations –– 8D64.1Y Other specified non-communicating hydrocephalus –– 8D64.1Z Non-communicating hydrocephalus, unspecified 8D65 Cerebrospinal fluid fistula 8D66 Syringomyelia or syringobulbia – 8D66.0 Idiopathic syringomyelia – 8D66.1 Syringomyelia due to certain specified cause – 8D66.2 Syringobulbia – 8D66.Y Other specified syringomyelia or syringobulbia – 8D66.Z Syringomyelia or syringobulbia, unspecified 8D67 Intracranial arachnoid cyst 8D68 Porencephalic cyst 8D6Y Other specified disorders of cerebrospinal fluid pressure or flow 8D6Z Disorders of cerebrospinal fluid pressure or flow, unspecified 8D80 Congenital malformations of the autonomic nervous system 8D81 Inherited autonomic nervous system disorders 8D82 Autoimmune disorders involving the autonomic nervous system 8D83 Autonomic nervous system disorder due to infection 8D84 Pure autonomic nervous system failure 8D85 Autonomic nervous system disorder due to substances 8D86 Autonomic nervous system hyperactivity 8D87 Autonomic nervous system disorder due to certain specified neurodegenerative disorder – 8D87.0 Multiple system atrophy – 8D87.Y Other specified autonomic nervous system disorder due to specified neurodegenerative disorder –– 8D87.00 Multiple system atrophy, Cerebellar type –– 8D87.01 Multiple system atrophy, Parkinsonism –– 8D87.0Y Other specified multiple system atrophy –– 8D87.0Z Multiple system atrophy, unspecified 8D88 Autonomic neuropathies – 8D88.0 Autonomic neuropathy due to sodium channelopathies – 8D88.1 Autonomic neuropathy due to diabetes mellitus – 8D88.2 Immune mediated autonomic neuropathy – 8D88.3 Autonomic disorder due to toxins – 8D88.4 Autonomic neuropathy in endocrine and metabolic diseases – 8D88.Y Other specified autonomic neuropathies – 8D88.Z Autonomic neuropathies, unspecified 8D89 Disorders of orthostatic tolerance – 8D89.0 Reflex syncope – 8D89.1 Syncope due to autonomic failure – 8D89.2 Postural orthostatic tachycardia syndrome – 8D89.3 Baroreflex failure – 8D89.Y Other specified disorders of orthostatic tolerance – 8D89.Z Disorders of orthostatic tolerance, unspecified 8D8A Focal or segmental autonomic disorders – 8D8A.1 Horner syndrome – 8D8A.2 Episodic anisocoria – 8D8A.Y Other specified focal or segmental autonomic disorders – 8D8A.Z Focal or segmental autonomic disorders, unspecified 8D8B Disorders affecting autonomic synaptic neurotransmission 8D8C Autonomic dysreflexia 8D8D Hypoglycaemia unawareness 8D8Y Other specified disorders of autonomic nervous system 8D8Z Disorders of autonomic nervous system, unspecified 8E00 Sporadic Creutzfeldt-Jakob Disease 8E01 Acquired prion disease – 8E01.0 Iatrogenically acquired Creutzfeldt-Jakob Disease – 8E01.1 Kuru – 8E01.2 Variant Creutzfeldt-Jakob Disease – 8E01.3 Other acquired Creutzfeldt-Jakob Disease – 8E01.Z Acquired prion disease, unspecified 8E02 Genetic prion diseases – 8E02.0 Genetic Creutzfeldt-Jakob disease – 8E02.1 Gerstmann-Straussler-Scheinker syndrome – 8E02.2 Fatal familial insomnia – 8E02.3 Other genetic prion diseases – 8E02.Y Other specified Creutzfeldt-Jakob disease – 8E02.Z Creutzfeldt-Jakob disease, unspecified 8E03 Variably protease sensitive prionopathy 8E0Y Other specified human prion diseases 8E0Z Human prion diseases, unspecified 8E20 Persistent vegetative state 8E21 Permanent vegetative state 8E22 Minimally conscious state – 8E22.0 Minimally conscious state plus – 8E22.1 Minimally conscious state minus – 8E22.Y Other specified minimally conscious state – 8E22.Z Minimally conscious state, unspecified 8E2Y Other specified disorders of consciousness 8E2Z Disorders of consciousness, unspecified 8E60 Post ventricular shunting leak 8E61 Post radiation injury of the nervous system – 8E61.0 Radiation-induced brain injury – 8E61.1 Spinal cord irradiation – 8E61.Z Post radiation injury of the nervous system, unspecified 8E62 Postprocedural meningitis 8E63 Post pump encephalopathy 8E64 Multifocal cerebral infarctions 8E66 Intracranial hypotension due to lumbar puncture – JB64.3 Diseases of the nervous system complicating pregnancy, childbirth or the puerperium – LA00 Anencephaly or similar anomalies –– LA00.0 Anencephaly –– LA00.1 Iniencephaly –– LA00.2 Acephaly –– LA00.3 Amyelencephaly –– LA00.Y Other specified anencephaly or similar anomalies –– LA00.Z Anencephaly or similar anomalies, unspecified ––– LA00.00 Craniorachischisis ––– LA00.0Y Other specified anencephaly ––– LA00.0Z Anencephaly, unspecified – LA01 Cephalocele – LA02 Spina bifida –– LA02.0 Spina bifida cystica –– LA02.1 Spina bifida aperta –– LA02.Y Other specified spina bifida –– LA02.Z Spina bifida, unspecified ––– LA02.00 Myelomeningocele with hydrocephalus ––– LA02.01 Myelomeningocele without hydrocephalus ––– LA02.02 Myelocystocele ––– LA02.0Y Other specified spina bifida cystica ––– LA02.0Z Spina bifida cystica, unspecified – LA03 Arnold-Chiari malformation type II – LA04 Congenital hydrocephalus –– LA04.0 Hydrocephalus with stenosis of the aqueduct of Sylvius –– LA04.Y Other specified congenital hydrocephalus –– LA04.Z Congenital hydrocephalus, unspecified – LA05 Cerebral structural developmental anomalies –– LA05.0 Microcephaly –– LA05.1 Megalencephaly –– LA05.2 Holoprosencephaly –– LA05.3 Corpus callosum agenesis –– LA05.4 Arrhinencephaly –– LA05.5 Abnormal neuronal migration –– LA05.6 Encephaloclastic disorders –– LA05.7 Brain cystic malformations –– LA05.8 Colpocephaly –– LA05.Y Other specified cerebral structural developmental anomalies –– LA05.Z Cerebral structural developmental anomalies, unspecified ––– LA05.50 Polymicrogyria ––– LA05.51 Cortical dysplasia ––– LA05.5Y Other specified abnormal neuronal migration ––– LA05.5Z Abnormal neuronal migration, unspecified ––– LA05.60 Porencephaly ––– LA05.61 Schizencephaly ––– LA05.62 Hydranencephaly ––– LA05.6Y Other specified encephaloclastic disorders ––– LA05.6Z Encephaloclastic disorders, unspecified – LA06 Cerebellar structural developmental anomalies –– LA06.0 Dandy-Walker malformation –– LA06.1 Hypoplasia or agenesis of cerebellar hemispheres –– LA06.2 Focal cerebellar dysplasia –– LA06.Y Other specified cerebellar structural developmental anomalies –– LA06.Z Cerebellar structural developmental anomalies, unspecified – LA07 Structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column –– LA07.0 Primary tethered cord syndrome –– LA07.1 Diastematomyelia –– LA07.2 Amyelia –– LA07.3 Primary syringomyelia or hydromyelia –– LA07.4 Arnold-Chiari malformation type I –– LA07.Y Other specified structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column –– LA07.Z Structural developmental anomalies of the neurenteric canal, spinal cord or vertebral column, unspecified – LA0Y Other specified structural developmental anomalies of the nervous system – LA0Z Structural developmental anomalies of the nervous system, unspecified LD20 Syndromes with central nervous system anomalies as a major feature – LD20.0 Syndromes with cerebellar anomalies as a major feature – LD20.1 Syndromes with lissencephaly as a major feature – LD20.2 Syndromes with microcephaly as a major feature – LD20.3 Syndromes with holoprosencephaly as a major feature – LD20.4 Syndromes with brain calcifications as a major feature – LD20.Y Other specified syndromes with central nervous system anomalies as a major feature – LD20.Z Syndromes with central nervous system anomalies as a major feature, unspecified –– LD20.00 Joubert syndrome –– LD20.01 Pontocerebellar hypoplasia –– LD20.0Y Other specified syndromes with cerebellar anomalies as a major feature –– LD20.0Z Syndromes with cerebellar anomalies as a major feature, unspecified – MB40 Sensation disturbance –– MB40.0 Asomatognosia –– MB40.1 Allodynia –– MB40.2 Anacusis –– MB40.3 Anaesthesia of skin –– MB40.4 Tingling fingers or feet or toes –– MB40.5 Hyperaesthesia –– MB40.6 Dysesthesia –– MB40.7 Acroparaesthesia –– MB40.8 Analgesia –– MB40.9 Neurological neglect syndrome –– MB40.Y Other specified sensation disturbance –– MB40.Z Sensation disturbance, unspecified – MB41 Disturbances of smell and taste –– MB41.0 Anosmia –– MB41.1 Parosmia –– MB41.2 Dysgeusia –– MB41.3 Hyposmia –– MB41.Y Other specified disturbances of smell and taste –– MB41.Z Disturbances of smell and taste, unspecified – MB42 Phonophobia – MB43 Dyssomnia – MB44 Abnormalities of gait and mobility –– MB44.0 Ataxic gait –– MB44.1 Paralytic gait –– MB44.2 Difficulty in walking –– MB44.3 Immobility –– MB44.Y Other specified abnormalities of gait and mobility –– MB44.Z Abnormalities of gait and mobility, unspecified – MB45 Lack of coordination –– MB45.0 Ataxia, unspecified –– MB45.1 Automatism –– MB45.2 Atonia –– MB45.3 Head drop –– MB45.4 Intention tremor –– MB45.Y Other specified lack of coordination –– MB45.Z Lack of coordination, unspecified – MB46 Abnormal involuntary movements –– MB46.0 Asterixis –– MB46.1 Abnormal head movements –– MB46.2 Athetosis –– MB46.3 Drop attack –– MB46.4 Titubation –– MB46.5 Shuddering –– MB46.Y Other specified abnormal involuntary movements –– MB46.Z Abnormal involuntary movements, unspecified – MB47 Abnormality of tonus and reflex –– MB47.0 Abnormal reflex –– MB47.1 Abnormal posture –– MB47.2 Clonus –– MB47.3 Cramp or spasm –– MB47.4 Dystonia –– MB47.5 Fasciculation –– MB47.6 Meningismus –– MB47.7 Muscle fibrillation –– MB47.8 Muscular hypertonia –– MB47.9 Myotonia –– MB47.A Ophthalmoparesis –– MB47.B Opisthotonos –– MB47.C Tendency to fall –– MB47.D Tetany –– MB47.Y Other specified abnormality of tonus and reflex –– MB47.Z Abnormality of tonus and reflex, unspecified – MB48 Dizziness and giddiness –– MB48.0 Vertigo –– MB48.1 Disorder of equilibrium –– MB48.2 Exertional dizziness –– MB48.3 Light-headedness –– MB48.4 Presyncope –– MB48.Y Other specified dizziness and giddiness –– MB48.Z Dizziness and giddiness, unspecified ––– MB48.00 Vertigo of central origin ––– MB48.0Y Other specified vertigo ––– MB48.0Z Vertigo, unspecified – MB49 Aura – MB4A Apraxia – MB4B Symbolic dysfunctions –– MB4B.0 Dyslexia and alexia –– MB4B.1 Agnosia –– MB4B.2 Acalculia –– MB4B.3 Agraphia –– MB4B.4 Anomia –– MB4B.5 Dyscalculia –– MB4B.Y Other specified symbolic dysfunctions –– MB4B.Z Symbolic dysfunctions, unspecified – MB4C Gerstmann syndrome – MB4D Headache, not elsewhere classified –– MB50 Tetraplegia ––– MB50.0 Flaccid tetraplegia ––– MB50.1 Spastic tetraplegia ––– MB50.Z Tetraplegia, unspecified –– MB51 Diplegia of upper extremities ––– MB51.0 Flaccid diplegia of upper extremities ––– MB51.1 Spastic diplegia of upper extremities ––– MB51.Z Diplegia of upper extremities, unspecified –– MB52 Diplegia of lower extremities –– MB53 Hemiplegia ––– MB53.0 Alternating hemiplegia ––– MB53.1 Flaccid hemiplegia ––– MB53.2 Spastic hemiplegia ––– MB53.Z Hemiplegia, unspecified –– MB54 Monoplegia of upper extremity ––– MB54.0 Flaccid monoplegia of upper extremity ––– MB54.1 Spastic monoplegia of upper extremity ––– MB54.Z Monoplegia of upper extremity, unspecified –– MB55 Monoplegia of lower extremity ––– MB55.0 Flaccid monoplegia of lower extremity ––– MB55.1 Spastic monoplegia of lower extremity ––– MB55.Z Monoplegia of lower extremity, unspecified –– MB56 Paraplegia –– MB57 Functional level of injury of spinal cord ––– MB57.0 Functional level of injury of cervical spinal cord ––– MB57.1 Functional level of injury of thoracic spinal cord ––– MB57.2 Functional level of injury of lumbar spinal cord ––– MB57.3 Functional level of injury of spinal cord, sacrum ––– MB57.Y Other specified functional level of injury of spinal cord ––– MB57.Z Functional level of injury of spinal cord, unspecified –– MB5Y Other specified paralytic symptoms –– MB5Z Paralytic symptoms, unspecified – MB60 Sleeptalking – MB6Y Other specified symptoms or signs involving the nervous system – MB70 Clinical findings in cerebrospinal fluid –– MB70.0 Abnormal level of enzymes in cerebrospinal fluid –– MB70.1 Abnormal level of hormones in cerebrospinal fluid –– MB70.2 Abnormal level of drugs, medicaments and biological substances in cerebrospinal fluid –– MB70.3 Abnormal level of substances chiefly nonmedicinal as to source in cerebrospinal fluid –– MB70.4 Abnormal immunological findings in cerebrospinal fluid –– MB70.5 Abnormal microbiological findings in cerebrospinal fluid –– MB70.6 Abnormal cytological findings in cerebrospinal fluid –– MB70.7 Abnormal histological findings in cerebrospinal fluid –– MB70.8 Other abnormal findings in cerebrospinal fluid –– MB70.Y Other specified clinical findings in cerebrospinal fluid –– MB70.Z Clinical findings in cerebrospinal fluid, unspecified – MB71 Clinical findings on diagnostic imaging of central nervous system –– MB71.0 Intracranial space-occupying lesion –– MB71.Y Other specified clinical findings on diagnostic imaging of central nervous system –– MB71.Z Clinical findings on diagnostic imaging of central nervous system, unspecified – MB72 Results of function studies of the nervous system – MB7Y Other specified clinical findings in the nervous system MB9Y Other specified symptoms, signs or clinical findings of the nervous system –– MB50 Tetraplegia ––– MB50.0 Flaccid tetraplegia ––– MB50.1 Spastic tetraplegia ––– MB50.Z Tetraplegia, unspecified –– MB51 Diplegia of upper extremities ––– MB51.0 Flaccid diplegia of upper extremities ––– MB51.1 Spastic diplegia of upper extremities ––– MB51.Z Diplegia of upper extremities, unspecified –– MB52 Diplegia of lower extremities –– MB53 Hemiplegia ––– MB53.0 Alternating hemiplegia ––– MB53.1 Flaccid hemiplegia ––– MB53.2 Spastic hemiplegia ––– MB53.Z Hemiplegia, unspecified –– MB54 Monoplegia of upper extremity ––– MB54.0 Flaccid monoplegia of upper extremity ––– MB54.1 Spastic monoplegia of upper extremity ––– MB54.Z Monoplegia of upper extremity, unspecified –– MB55 Monoplegia of lower extremity ––– MB55.0 Flaccid monoplegia of lower extremity ––– MB55.1 Spastic monoplegia of lower extremity ––– MB55.Z Monoplegia of lower extremity, unspecified –– MB56 Paraplegia –– MB57 Functional level of injury of spinal cord ––– MB57.0 Functional level of injury of cervical spinal cord ––– MB57.1 Functional level of injury of thoracic spinal cord ––– MB57.2 Functional level of injury of lumbar spinal cord ––– MB57.3 Functional level of injury of spinal cord, sacrum ––– MB57.Y Other specified functional level of injury of spinal cord ––– MB57.Z Functional level of injury of spinal cord, unspecified –– MB5Y Other specified paralytic symptoms –– MB5Z Paralytic symptoms, unspecified
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com